Byrna (BYRN) 10-K 13 Mar 17 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Nov. 30, 2016	Mar. 09, 2017	May 31, 2016
Document Type	10-K
Amendment Flag	false
Document Period End Date	Nov. 30, 2016
Trading Symbol	sdev
Entity Registrant Name	Security Devices International Inc.
Entity Central Index Key	1,354,866
Current Fiscal Year End Date	--11-30
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		56,197,158
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Entity Public Float			$ 6,800,000
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY

Interim Consolidated Balance Sh

Interim Consolidated Balance Sheets - USD ($)	Nov. 30, 2016	Nov. 30, 2015
CURRENT
Cash	$ 192,826	$ 1,851,021
Accounts Receivable	32,534	39,676
Inventory	7,323	44,319
Deferred financing costs	35,769	52,946
Prepaid expenses and other receivables	50,037	27,283
Total Current Assets	318,489	2,015,245
Deferred financing costs	36,874	36,024
Property and Equipment	50,496	97,011
TOTAL ASSETS	405,859	2,148,280
CURRENT LIABILITIES
Accounts payable and accrued liabilities	245,911	173,329
Convertible Debentures	1,153,540	0
Total Current Liabilities	1,399,451	173,329
Convertible Debentures	0	1,161,750
Total Liabilities	1,399,451	1,335,079
Capital Stock
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (2015 - nil).	0	0
Common stock, $0.001 par value 100,000,000 shares authorized, 55,104,493 issued and outstanding (2015: 54,615,642)	55,105	54,616
Additional Paid-In Capital	27,307,274	27,179,827
Accumulated deficit	(28,298,613)	(26,374,503)
Accumulated other comprehensive loss	(57,358)	(46,739)
Total Stockholders' Equity (Deficiency)	(993,592)	813,201
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)	$ 405,859	$ 2,148,280

Interim Consolidated Balance S3

Interim Consolidated Balance Sheets (Parenthetical) - $ / shares	Nov. 30, 2016	Nov. 30, 2015
Preferred Stock, Par Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	55,104,493	54,615,642
Common Stock, Shares, Outstanding	55,104,493	54,615,642

Interim Consolidated Statements

Interim Consolidated Statements of Operations and Comprehensive loss - USD ($)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
SALES	$ 154,015	$ 151,005
COST OF SALES	(95,017)	(115,940)
GROSS PROFIT	58,998	35,065
EXPENSES:
Depreciation	46,515	47,165
Foreign currency translation gain	(18,749)	(179,537)
General and administration	1,723,310	2,306,940
TOTAL OPERATING EXPENSES	1,751,076	2,174,568
LOSS FROM OPERATIONS	(1,692,078)	(2,139,503)
Other Expense-Interest	(232,032)	(231,398)
LOSS BEFORE INCOME TAXES	(1,924,110)	(2,370,901)
Income taxes	0	0
NET LOSS	(1,924,110)	(2,370,901)
Foreign exchange translation adjustment for the year	(10,619)	(15,033)
COMPREHENSIVE LOSS	$ (1,934,729)	$ (2,385,934)
Loss per share - basic and diluted	$ (0.04)	$ (0.05)
Weighted average number of common shares outstanding during the year	54,704,037	50,394,435

Interim Consolidated Statement5

Interim Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the year	$ (1,924,110)	$ (2,370,901)
Items not requiring an outlay of cash:
Fair value of issue of options (included in general and administration expenses)	28,024	422,459
Fair value of modification of options and warrants (included in general and administration expenses)	49,912	216,684
Amortization of deferred financing costs	63,740	63,566
Foreign currency translation gain	(18,749)	(179,537)
Depreciation	46,515	47,165
Changes in non-cash working capital:
Accounts receivable	6,989	(31,326)
Inventory	36,996	75,927
Prepaid expenses and other receivables	(22,838)	1,807
Accounts payable and accrued liabilities	73,382	15,332
NET CASH USED IN OPERATING ACTIVITIES	(1,660,139)	(1,738,824)
CASH FLOWS FROM FINANCING ACTIVITIES
Net Proceeds from issuance of common stock	0	2,500,000
Deferred financing costs incurred	(36,874)	0
Exercise of stock options and warrants	0	23,770
NET CASH PROVIDED (USED) BY FINANCING ACTIVITIES	(36,874)	2,523,770
Effects of foreign currency exchange rate changes	38,818	(18,931)
NET INCREASE (DECREASE) IN CASH FOR THE YEAR	(1,658,195)	766,015
Cash, beginning of Year	1,851,021	1,085,006
CASH END OF YEAR	192,826	1,851,021
SUPPLEMENTAL INFORMATION:
INCOME TAXES PAID	0	0
INTEREST PAID	$ 161,372	$ 167,831

Interim Consolidated Statement

Interim Consolidated Statement of Changes in Stockholders Equity (Deficiency) - USD ($)	Common Shares [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive loss [Member]	Total
Beginning Balance at Nov. 30, 2014	$ 46,899	$ 24,024,631	$ (24,003,602)	$ (31,706)	$ 36,222
Beginning Balance (Shares) at Nov. 30, 2014	46,899,285
Issue of common shares	$ 7,576	2,492,424			2,500,000
Issue of common shares (Shares)	7,575,757
Exercise of options	$ 35	6,960			6,995
Exercise of options (Shares)	35,000
Exercise of warrants	$ 106	16,669			16,775
Exercise of warrants (Shares)	105,600
Stock based compensation for issue of options		422,459			422,459
Stock based compensation for modification of warrants		216,684			216,684
Net loss for the period			(2,370,901)		(2,370,901)
Foreign currency translation				(15,033)	(15,033)
Ending Balance at Nov. 30, 2015	$ 54,616	27,179,827	(26,374,503)	(46,739)	813,201
Ending Balance (Shares) at Nov. 30, 2015	54,615,642
Issuance of common shares For services	$ 489	49,511			50,000
Issuance of common shares For services (Shares)	488,851
Stock based compensation for issue of options		28,024			28,024
Stock based compensation for modification of warrants		49,912			49,912
Net loss for the period			(1,924,110)		(1,924,110)
Foreign currency translation				(10,619)	(10,619)
Ending Balance at Nov. 30, 2016	$ 55,105	$ 27,307,274	$ (28,298,613)	$ (57,358)	$ (993,592)
Ending Balance (Shares) at Nov. 30, 2016	55,104,493

BASIS OF PRESENTATION

BASIS OF PRESENTATION	12 Months Ended
	Nov. 30, 2016
BASIS OF PRESENTATION [Text Block]	1. BASIS OF PRESENTATION The Company was incorporated under the laws of the state of Delaware on March 1, 2005. On February 3, 2014 the Company incorporated a wholly owned subsidiary in Canada “Security Devices International Canada Corp”. The consolidated financial statements for the year ended November 30, 2016 include the accounts of Security Devices International, Inc. (the “Company” or “SDI”), and its subsidiary Security Devices International Canada Corp. All material inter-company accounts and transactions have been eliminated.

NATURE OF OPERATIONS AND GOING

NATURE OF OPERATIONS AND GOING CONCERN	12 Months Ended
	Nov. 30, 2016
NATURE OF OPERATIONS AND GOING CONCERN [Text Block]	2. NATURE OF OPERATIONS AND GOING CONCERN The Company is a less-lethal defense technology company, specializing in the innovative next generation solutions for security situations that do not require the use of lethal force. SDI has implemented manufacturing partnerships to assist in the deployment of their patented and patent pending family of products. These products consist of the current manufacture of Blunt Impact Projectile 40mm (BIP) line of products, and the future Wireless Electric Projectile 40mm (WEP). These financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. The Company’s activities are subject to risk and uncertainties including- The Company has not earned adequate revenue and has used cash in its operations. Therefore the company will need additional financing to continue its operations if it is unable to generate substantial revenue growth. The Company has incurred a cumulative loss of $28,298,613 from inception to November 30, 2016. The Company has funded operations through the issuance of capital stock and convertible debentures. The company has started to generate revenue from operations. However, it still expects to incur significant expenses before becoming profitable. The Company’s future success is dependent upon its ability to raise sufficient capital or generate adequate revenue, to cover its ongoing operating expenses, and also to continue to develop and be able to profitably market its products. There can be no assurance that such financing will be available at all or on favorable terms. These factors raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. In addition to raising funds in the prior years, the Company raised $878,328 by issue of Convertible Debentures during the year ended November 30, 2011 and $910,000 during the year ended November 30, 2012. In addition, the Company raised $649,750 by issuance of 2,165,834 common shares during the year ended November 30, 2012. On August 15, 2013, the Company filed an amended and restated final prospectus (the “Prospectus”) in Canada, in the provinces of Alberta, British Columbia and Ontario for listing its shares in these provinces in Canada. On August 27, 2013 the Company completed an initial public offering to raise gross proceeds of CAD $3,993,980 (US $3,794,280) through the issuance of 9,984,950 Common Shares at a price of CAD $0.40 (US $0.38) per Common Share (the “Issue Price”). During the year ended November 30, 2014, the Company issued $1,398,592 (CAD $1,549,000) face value 12% convertible debentures with a term to August 6, 2017 (the “Maturity Date”) and raised net $1,241,299. In 2015, the Company raised $2,500,000 through the issuance of 7,575,757 common shares and also issued 105,600 common shares on exercise of warrants for $16,775 and 35,000 common shares on exercise of options for $6,995. Subsequent to the year the Company raised an additional gross $1,500,000 through the issuance of convertible debentures.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Nov. 30, 2016
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Text Block]	3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES a) Use of Estimates The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, and reported amount of revenues and expenses. Significant estimates include accruals, valuation allowance for deferred tax assets, estimates for calculation of stock based compensation, estimating the useful life of its plant and equipment and accounting for conversion features on convertible debt transactions. These estimates are based on management’s best estimates and judgment. Management will adjust such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with certainty, actual results could differ significantly from these estimates. b) Income Taxes The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10- 25”). Under ASC 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740- 10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets is not more than likely. The Company did not incur any material impact to its financial condition or results of operations due to the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. c) Revenue Recognition The Company records revenue when it is realized, or realizable and earned. The Company considers revenue to be realized, or realizable and earned, when the following revenue recognition requirements are met: persuasive evidence of an arrangement exists; the products have been delivered to the customer; the sales price is fixed or determinable; and collectability is reasonably assured. d) Loss Per Share Basic loss per share is computed by dividing net loss by the weighted average number of common shares outstanding for the year. Diluted loss per share is computed by dividing net loss by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. There were no common equivalent shares outstanding at November 30, 2016 and 2015 that have been included in dilutive loss per share calculation as the effects would have been anti-dilutive. At November 30, 2016, there were 4,625,000 options and 2,484,650 warrants outstanding, which were convertible into equal number of common shares of the Company. At November 30, 2015, there were 4,750,000 options and 2,767,800 warrants outstanding, which were convertible into equal number of common shares of the Company. e) Stock-Based Compensation All awards granted to employees and non-employees after November 30, 2006 are valued at fair value by using the Black-Scholes option pricing model and recognized on a straight line basis over the service periods of each award. The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees using the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earlier of a performance commitment or completion of performance by the provider of goods or services. If there is a modification of the terms of an award, either by repricing or extending the expiry of the award, the award is re-measured. If the modification results in an increase in the fair value of the new award as compared to the old award immediately prior to the modification, the excess fair value is recognized as compensation expense. f) Foreign Currency The parent Company maintains its books and records in U.S. dollars which is its functional and reporting currency. The Company’s operating subsidiary is a foreign private company and maintains its books and records in Canadian dollars (the functional currency). The subsidiary’s financial statements are converted to US dollars for consolidation purposes. The translation method used is the current rate method. Under the current rate method all assets and liabilities are translated at the current rate, stockholders’ equity accounts are translated at historical rates and revenues and expenses are translated at average rates for the year. The resulting translation adjustment has been included in Accumulated Other Comprehensive Income (Loss). g) Comprehensive loss Comprehensive loss includes all changes in equity (net assets) during a period from non- owner sources. Items included in comprehensive loss, which are excluded from net loss, include foreign currency translation adjustments relating to its Canadian subsidiary. h) Financial Instruments The carrying amount of accounts and other receivable and accounts payable, approximated their fair value because of the relatively short maturity of these instruments. The Company determines fair value based on its accounting policy fair value measurement i.e. exit price that would be recovered for an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The Company does not use derivative financial instruments such as forwards to hedge foreign currency exposures. i) Fair Value Measurement The Company follows ASC 820-10, “Fair Value Measurements and Disclosures” (ASC 820-10), which among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, a three-tier fair value hierarchy has been established, which prioritizes the inputs used in measuring fair value as follows: • • • Assets and liabilities measured at fair value as of November 30, 2016 and 2015 are classified below based on the three fair value hierarchy tiers described above: Carrying Fair Value Value November 30, 2016: Cash $ 192,826 $ 192,826 Accounts receivable $ 32,534 $ 32,534 Accounts payable and accrued liabilities $ 245,911 $ 245,911 Convertible debentures $ 1,153,540 $ 1,153,540 Carrying Fair Value Value (Restated) (Restated) November 30, 2015: (See Note 17) (See Note 17) Cash $ 1,851,021 $ 1,851,021 Accounts receivable $ 39,676 $ 39,676 Accounts payable and accrued liabilities $ 173,329 $ 173,329 Convertible debentures $ 1,161,750 $ 1,161,750 Cash has been measured using Level 1 of the Fair Value Hierarchy The carrying values of cash, accounts receivable, accounts payable and accrued liabilities and convertible debentures approximate their fair values because of the short-term nature of these instruments. j) Convertible debt instruments The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 Debt with Conversion and Other Options k) Intellectual Property Five patent applications, four non-provisional and one provisional, have been filed by the Company with the U.S. Patent Office. The Patents have been granted on the four non-provisional patents. Non-Provisional (granted patents): (a) Less-lethal Projectile: This issued patent relates to the Company’s distinctive collapsible ammunition head technology that absorbs kinetic energy of the projectile upon impact. The Corporation’s collapsible head is used in both the BIP and the WEP. (b) Electronic Circuitry for Incapacitating a Living Target: This issued patent relates to the electronic circuitry incapacitation system which forms part of the WEP. The patent describes an electronic circuit which provides an electrical incapacitation current to a living target. (c) Less-lethal Wireless Stun Projectile System for Immobilizing a Target by Neuro-Muscular Disruption: This issued patent describes the process by which the WEP operates with its attachment system to halt a target through a neuro-muscular-disruption system. (d) Autonomous Operation of a Less-lethal Projectile: This patent describes a motion sensing system within the WEP. The sensor will monitor movement of the target and enable the electrical output until the target is subdued. The electrical pulse is programmed for an exact time-frame to specifications of the user. Provisional Patent: (e) Payload carrying arrangement for a non-lethal projectile: This Provisional patent relates to the process of carrying liquid and powder payloads in the head of the BIP munitions that upon impact release from the head and are dispersed upon the target. The Company’s policy has been to write off cost incurred in connection with non-provisional and provisional patent costs as they are incurred as a recoverability of such expenditure is uncertain. l) Property and Equipment Property and equipment are recorded at cost less accumulated depreciation. Depreciation is provided commencing in the month following acquisition using the following annual rate and method: Computer equipment 30% declining balance method Furniture and fixtures 30% declining balance method Leasehold Improvements straight line over period of lease Moulds 20% Straight line over 5 years m) Impairment of Long-lived Assets Long-lived assets to be held and used are analyzed for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. The Company evaluates at each balance sheet date whether events and circumstances have occurred that indicate possible impairment. If there are indications of impairment, the Company uses future undiscounted cash flows of the related asset or asset group over the remaining life in measuring whether the assets are recoverable. In the event such cash flows are not expected to be sufficient to recover the recorded asset values, the assets are written down to their estimated fair value. n) Inventories Inventories comprise primarily of Blunt Impact Projectiles (Finished goods) and are valued at the lower of cost and net realizable value with cost being determined on the first-in, first-out basis. Costs consist of sub contracted manufacturing costs. o) Consolidation These consolidated financial statements include the accounts of Security Devices International Inc. and entities it controls. Control exists when SDI has the power, directly or indirectly, to govern the financial and operating policies of an entity/arrangement to obtain benefit from its activities. In assessing control, potential voting rights that currently are exercisable are considered. The financial statement of subsidiaries is included in the consolidated financial statements from the date that control commences until the date that control ceases. These consolidated financial statements include the results of SDI and its wholly-owned subsidiary, Security Devices International Canada Corp. p) Recent Accounting Pronouncements In January 2015, the FASB issued ASU No. 2015-01, "Income Statement - Extraordinary and Unusual Items (Subtopic 225-20) Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items" (ASU 2015-01). The amendments in ASU 2015-01 eliminate the GAAP concept of extraordinary items and no longer requires that transactions that met the criteria for classification as extraordinary items be separately classified and reported in the financial statements. ASU 2015-01 retains the presentation and disclosure guidance for items that are unusual in nature or occur infrequently and expands them to include items that are both unusual in nature and infrequently occurring. ASU 2015-01 will become effective in fiscal 2017. The Company is in the process of evaluating the amendments to determine if they have a material impact on the Company’s financial position, results of operations or cash flow. In February, 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis. ASU No. 2015-02 provides guidance on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities such as limited partnerships, limited liability corporations, and securitization structures (collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). ASU No. 2015-02 is effective for periods beginning after December 15, 2015, with early adoption permitted. The Company is in the process of evaluating the amendments to determine if they have a material impact on the Company’s financial position, results of operations or cash flow. In April 2015, the FASB issued ASU No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. ASU No. 2015-03 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015 with early adoption permitted. The Company is in the process of evaluating the amendments to determine if they have a material impact on the Company’s financial position, results of operations or cash flow. In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes,” as part of its simplification initiative. Under the ASU, organizations that present a classified balance sheet are required to classify all deferred taxes as noncurrent assets or noncurrent liabilities. ASU No. 2015-17 is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company is in the process of evaluating the amendments to determine if they have a material impact on the Company’s financial position, results of operations or cash flow. In January 2016, the FASB issued ASU 2016-01, which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The new standard significantly revises an entity’s accounting related to (1) the classification and measurement of investments in equity securities and (2) the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. ASU No. 2016-01 is effective for fiscal years beginning after December 15, 2017, and interim periods within those annual periods. The Company is in the process of evaluating the amendments to determine if they have a material impact on the Company’s financial position, results of operations or cash flow. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) In March 2016, the FASB issued ASU 2016-09, Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing In May 2016, the FASB issued ASU 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments In August 2016, the FASB issued ASU 2016-15, "Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments" (ASU 2016-15. The new guidance clarifies eight cash flow classification issues where current GAAP was either unclear or has no specific guidance. The new standard is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those fiscal years. All entities may elect to early adopt ASU 2016-15 in any interim period. If an entity early adopts it must adopt all eight of the amendments in the same period and if early adopted in an interim period any adjustments should be reflected as of the beginning of the year. The amendments in ASU 2016-15 will be applied using the modified retrospective transition method for each period presented. The Company is evaluating the impact the adoption of this guidance will have on the classification of certain items on its consolidated statements of cash flows. In January 2017, the FASB issued ASU No. 2017-01 Business Combinations (Topic 805) - Clarifying the Definition of a Business. This update clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments provide a screen to determine when a set of assets and activities is not a business. If the screen is not met, the amendments require further consideration of inputs, substantive processes and outputs to determine whether the transaction is an acquisition of a business. The new update is effective for annual periods beginning after December 15, 2017. The amendments in ASU 2017-01 will be implemented on a prospective basis.

ACCOUNTS PAYABLE AND ACCRUED LI

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	12 Months Ended
	Nov. 30, 2016
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES [Text Block]	4. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES 2016 2015 Accounts payable and accrued liabilities are comprised of the following: Trade payables $ 85,603 $ 69,962 Accrued liabilities-accrued interest $ 54,259 $ 53,339 Accrued liabilities-other liabilities $ 106,049 $ 50,028 $ 245,911 $ 173,329 Accrued liabilities-other liabilities relate primarily to professional fees.

CAPITAL STOCK

CAPITAL STOCK	12 Months Ended
	Nov. 30, 2016
CAPITAL STOCK [Text Block]	5. CAPITAL STOCK a) Authorized 100,000,000 * Common shares, $0.001 par value And 5,000,000 Preferred shares, $0.001 par value *On March 20, 2013 the Company filed with the Secretary of the State of Delaware a certificate of amendment (the “Amendment”) to the Company’s certificate of incorporation. The Amendment increased the number of authorized shares of the Company’s common stock, par value $0.001, from 50,000,000 to 100,000,000 common shares. The Company’s Articles of Incorporation authorize its Board of Directors to issue up to 5,000,000 shares of preferred stock having par value of $0.001. The provisions in the Articles of Incorporation relating to the preferred stock allow the directors to issue preferred stock with multiple votes per share and dividend rights, which would have priority over any dividends paid with respect to the holders of SDI’s common stock. b) Issued 55,104,493 Common shares (2015: 54,615,642 Common shares) c) Changes to Issued Share Capital Year ended November 30, 2016 Effective July 21, 2016, Bryan Ganz was elected as a director of the Company. Prior to his appointment, effective May 1, 2016, the Company executed a one-year consulting agreement with a Corporation in which the said director has an ownership interest. For the consultant services, the consultant was paid cash for $50,000 and issued a value of $200,000 in Company’s stock in four quarterly instalments over the 12 -month period ending May 15, 2017. In September 2016, the Company issued 488,851 common stock to the consultant being the first quarterly instalment for a value of $50,000 which was due August 15, 2016. Year ended November 30, 2015 On June 3, 2015, the Company received $16,775 and $6,995 for the exercise of 105,600 warrants and 35,000 options respectively. On June 19, 2015, the Company issued 7,575,757 common stock at price of $0.33 (CAD $0.40) per share on a non-brokered private placement basis and raised $2,500,000. There were no broker commissions or fees associated with this subscription. The closing of the private placement was approved by the TSX-Venture Exchange, as required under stock exchange rules.

STOCK BASED COMPENSATION

STOCK BASED COMPENSATION	12 Months Ended
	Nov. 30, 2016
STOCK BASED COMPENSATION [Text Block]	6. STOCK BASED COMPENSATION Effective May 31, 2013, the Company adopted an incentive stock option plan (the “2013 Plan”), which replaces the stock option and stock bonus plans that were in place prior to adoption of the 2013 Plan. All outstanding options to purchase Common Shares granted by the Company under the prior plans are now governed by the 2013 Plan and the prior plans (an Incentive Stock Option Plan, a Non-Qualified Stock Option Plan, and a Stock Bonus Plan) have been terminated. The purpose of this Plan is to authorize the grant to Eligible Persons of the Company of Options to purchase Shares and thus benefit the Company by enabling it to attract, retain and motivate Eligible Persons by providing them with the opportunity, through Options, to acquire an increased proprietary interest in the Company. The maximum number of Shares which may be reserved for issuance to any one Consultant under the Plan, any other employer stock options plans or options for services, within any 12 -month period, shall be 2% of the Shares issued and outstanding at the time of the grant (on a non-diluted basis). The maximum number of Shares which may be reserved for issuance to Investor Relations Optionees under the Plan, any other employer stock options plans or options for services, within any 12 -month period shall be 2% of the Shares issued and outstanding at the time of the grant (on a non-diluted basis). The maximum number of Shares which may be reserved for issuance to insiders of the Company in any 12 -month period shall be 10% of the Shares issued and outstanding at the start of such 12 -month period (on a non-diluted basis). The purchase price (the “Price”) for the Shares under each Option shall be determined by the Board of Directors or Committee, as applicable, on the basis of the market price, where “market price” shall mean the prior trading day closing price of the Shares on any stock exchange on which the Shares are listed or last trading price on the prior trading day on any dealing network where the Shares trade, and where there is no such closing price or trade on the prior trading day, “market price” shall mean the average of the daily high and low board lot trading prices of the Shares on any stock exchange on which the Shares are listed or dealing network on which the Shares trade for the five (5) immediately preceding trading days. In the event the Shares are listed on the TSXV, the price may be the market price less any discounts from the market price allowed by the TSXV, subject to a minimum price of CDN$0.10. Year ended November 30, 2016 Warrants: On June 9, 2016, the board of directors extended the expiry dates of 400,000 warrants issued in 2012 to a director at exercise price of $0.20, from original expiry date of August 9, 2016 to August 7, 2020. The change in the terms of the warrants was determined to be a modification and not a cancellation and issuance of a new warrant. As a result of these modifications, the fair value of 400,000 warrants increased by $49,912. Fair value of warrants was calculated using the Black Scholes option pricing model with the following assumptions: Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% 101.25% to Volatility 150.29% Warrant modification expense $ 49,912 Stock Options On August 18, 2016, the board of directors granted options to a consultant to acquire a total of 25,000 common shares. These options were issued at an exercise price of $0.11 (CAD $0.14) per share and vest immediately with an expiry term of five years. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following assumptions: Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 163.68% Market price of Company’s common stock on date of grant of options $ 0.11 Stock-based compensation cost $ 2,574 On October 20, 2016, the board of directors granted options to a new director to acquire a total of 350,000 common shares. These options were issued at an exercise price of $0.08 (CAD $0.11) per share and vest immediately with an expiry term of five years. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following assumptions: Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 149.08% Market price of Company’s common stock on date of grant of options $0.08 Stock-based compensation cost $25,450 As of November 30, 2016, there was $Nil of unrecognized expense related to non-vested stock-based compensation arrangements granted. Year ended November 30, 2015 Warrants: On September 24, 2015, the board of directors extended the expiry dates of 572,000 warrants issued in 2010 to directors and officers at exercise price of $0.20, from original expiry date of September 30, 2015 to September 23, 2019. In addition, on same date, the board of directors extended the expiry dates of 1,470,000 warrants issued to directors and officers and 35,000 to a consultant, all issued in 2012 at exercise price of $0.13, from original expiry date of January 4, 2016 to September 23, 2019. The change in the terms of the warrants was determined to be a modification and not a cancellation and issuance of a new warrant. As a result of these modifications, the fair value of 2,077,000 warrants increased by $216,684. Fair value of warrants was calculated using the Black Scholes option pricing model with the following assumptions: Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% 17.29% to Volatility 134.39% Warrant modification expense $ 216,684 Stock Options: On October 20, 2015, the board of directors granted 1,350,000 options to directors and officers and 325,000 options to consultants to acquire a total of 1,675,000 common shares. These options were issued at an exercise price of $0.29 (CAD $0.38) per share and vest immediately with an expiry term of five years. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following assumptions: Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 134.39% Market price of Company’s common stock on date of grant of options $ 0.29 Stock-based compensation cost $ 422,459 As of November 30, 2015, there was $Nil of unrecognized expense related to non-vested stock-based compensation arrangements granted.

STOCK PURCHASE OPTIONS AND WARR

STOCK PURCHASE OPTIONS AND WARRANTS	12 Months Ended
	Nov. 30, 2016
STOCK PURCHASE OPTIONS AND WARRANTS [Text Block]	7. STOCK PURCHASE OPTIONS AND WARRANTS a) OPTIONS The following table summarizes the options outstanding under the Stock Option Plan: Number of options 2016 2015 Outstanding, beginning of year 4,750,000 3,360,000 Granted 375,000 1,675,000 Expired (100,000 ) (200,000 ) Exercised - (35,000 ) Forfeited - - Cancelled (400,000 ) (50,000 ) Outstanding, end of year 4,625,000 4,750,000 Exercisable, end of year 4,625,000 4,750,000 Year 2016 Number of Option price options Expiry date per share 2016 March 18, 2017 $ 0.31 350,000 August 5, 2017 $ 0.32 150,000 May 8, 2019 $ 0.32 600,000 September 10, 2019 $ 0.36 1,625,000 October 19, 2020 $ 0.29 1,525,000 August 17, 2021 $ 0.11 25,000 October 19, 2021 $ 0.08 350,000 TOTAL 4,625,000 Weighted average exercise price: Options outstanding at end of year $ 0.30 Options granted during the year 0.08 Options exercised during the year - Options expired during the year 0.45 Options cancelled during the year 0.33 Year 2015 Number of Option price options Expiry date per share 2015 October 25, 2016 $ 0.45 100,000 March 18, 2017 $ 0.31 350,000 August 5, 2017 $ 0.32 150,000 May 8, 2019 $ 0.32 600,000 September 10, 2019 $ 0.36 1,875,000 October 19, 2020 $ 0.29 1,675,000 TOTAL 4,750,000 Weighted average exercise price: Options outstanding at end of year $ 0.33 Options granted during the year 0.29 Options exercised during the year 0.20 Options expired during the year 0.42 Options cancelled during the year 0.31 The share options outstanding at the end of the year had a weighted average remaining contractual life as follows: 2016 2015 (Years) (Years) Total outstanding options 2.8 3.8 Total exercisable options 2.8 3.8 b) WARRANTS Number of Warrants Exercise Expiry Granted Prices Date $ Outstanding at November 30, 2014 and average exercise price 4,794,545 0.24 Granted in year 2015 - - Exercised (27,500 ) 0.20 Exercised (68,750 ) 0.13 Exercised (9,350 ) 0.25 Forfeited - - Expired (622,500 ) 0.20 Expired (75,000 ) 0.42 Expired (1,223,645 ) 0.47 Cancelled - - Outstanding at November 30, 2015 and average exercise price* 2,767,800 0.17 Granted in year 2016 - - Exercised - - Expired (131,250 ) 0.13 Expired (151,900 ) 0.45 Cancelled - - Outstanding at November 30, 2016 and average exercise price* 2,484,650 0.16 Exercisable at November 30, 2016 2,484,650 0.16 Exercisable at November 30, 2015 2,767,800 0.17 * On September 24, 2015, the board of directors extended the expiry dates of 572,000 warrants issued in 2010 and 1,505,000 warrants issued in 2012. In addition, on June 9, 2016, the board of directors extended the expiry of 400,000 warrants issued in 2012 by an additional 4 years (refer to note 6) The warrants outstanding at the end of the year had a weighted average remaining contractual life as follows: 2016 2015 (Years) (Years) Total outstanding warrants 3.25 2.87 Total exercisable warrants 3.25 2.87

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Nov. 30, 2016
RELATED PARTY TRANSACTIONS [Text Block]	8. RELATED PARTY TRANSACTIONS The following transactions are in the normal course of operations and are measured at the amount of consideration established and agreed to by the related parties. Year ended November 30, 2016 The directors were compensated as per their consulting agreements with the Company. The Company expensed a total of $219,000 as management fees to two of its ex-directors in their role as officers in accordance with their consulting contracts, which included $57,600 paid on full and final settlement to one director in his role as CEO on his resignation and termination effective July 15, 2016, and also expensed a total of $5,900 as automobile allowance. In addition, the Company expensed $42,200 as a consulting fee to an independent director for services provided. On June 9, 2016, the board of directors extended the expiry dates of 400,000 warrants issued in 2012 to a director at exercise price of $0.20, from original expiry date of August 9, 2016 to August 7, 2020. As a result of these modifications, the fair value of 400,000 warrants increased by $49,912. On October 20, 2016, the board of directors granted 350,000 options to a new director. These options were issued at an exercise price of $0.08 (CAD $0.11) per share and vest immediately with an expiry term of five years. The Company expensed stock based compensation cost of $25,450. Effective July 21, 2016, Bryan Ganz was elected as a director of the Company. Prior to his appointment, effective May 1, 2016, the Company executed a one-year consulting agreement with a Corporation in which the said director has an ownership interest. The said Corporation was paid cash of $25,000 in May, 2016 and $25,000 in June, 2016. In addition, in September 2016, the Company issued 488,851 shares for services at deemed price of $0.1023 (CAD$0.1322) for a total consideration of $50,000. The Company expensed $32,000 for services provided by the CFO of the Company and $186,800 for services provided by a Corporation in which the Chief Operating Officer has an ownership interest, in accordance with the consulting contract. The Company reimbursed $50,780 to directors and officers for travel and entertainment expenses incurred for the Company. Year ended November 30, 2015 Two non-independent directors were compensated as per their consulting agreements with the Company. The Company expensed a total of $212,505 as management fees to these two directors, in their role as officers in accordance with their consulting contracts and expensed a total of $5,721 as automobile allowance. On September 24, 2015, the board of directors extended the expiry dates of 572,000 warrants issued in 2010 to directors and officers at exercise price of $0.20, from original expiry date of September 30, 2015 to September 23, 2019. In addition, on same date, the board of directors extended the expiry dates of 1,470,000 warrants issued to directors and officers in 2012 at exercise price of $0.13, from original expiry date of April 1, 2016 to September 23, 2019. As a result of these modifications, the fair value of 2,042,000 warrants increased by $213,603. On October 20, 2015, the board of directors granted 1,350,000 options to directors and officers. These options were issued at an exercise price of $0.29 (CAD $0.38) per share and vest immediately with an expiry term of five years. The Company expensed stock based compensation cost of $340,489 for these 1,325,000 options issued to directors and officers. The Company expensed $35,717 for services provided by the CFO of the Company and $221,217 for services provided by a Corporation in which the Chief Operating Officer has an ownership interest, in accordance with the consulting contract. The Company reimbursed $89,538 to directors and officers for travel and entertainment expenses incurred for the Company.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Nov. 30, 2016
PROPERTY AND EQUIPMENT [Text Block]	9. PROPERTY AND EQUIPMENT Property and equipment are recorded at cost less accumulated depreciation. November November 30, 2016 Accumulated 30, 2015 Accumulated Cost Depreciation Cost Depreciation $ $ $ $ Computer equipment 37,573 35,410 37,573 34,483 Furniture and fixtures 18,027 16,648 18,027 16,057 Leasehold Improvements 23,721 19,338 23,721 16,244 Moulds 209,515 166,944 209,515 125,041 288,836 238,340 288,836 191,825 Net carrying amount $ 50,496 $ 97,011 Depreciation expense $ 46,515 $ 47,165

INCOME TAXES

INCOME TAXES	12 Months Ended
	Nov. 30, 2016
INCOME TAXES [Text Block]	10. INCOME TAXES The Company has non-capital losses of approximately $1 available, which can be applied against future taxable income and which expire as follows: USA Canada Total 2025 $ 188,494 188,494 2026 609,991 609,991 2027 1,731,495 1,731,495 2028 3,174,989 3,174,989 2029 2,792,560 2,792,560 2030 2,044,857 2,044,857 2031 854,218 854,218 2032 1,073,610 1,073,610 2033 1,410,557 1,410,557 2034 882,513 1,089,850 1,972,363 2035 722,853 1,124,876 1,847,729 2036 600,185 963,545 1,563,730 $ 16,086,322 3,178,271 19,264,593 The reconciliation of income taxes at statutory income tax rates (U.S – 35% and Canada – 26.5% on their respective losses) to the income tax expense is as follows: November November 30, 2016 30, 2015 (Restated) (See Note 17 ) Loss before income taxes $ (1,924,110 ) $ (2,331,734 ) Income tax recovery at statutory rate (592,327 ) (728,692 ) Permanent differences 49,587 245,949 Tax benefit not recognized 542,740 482,743 Income taxes – current and deferred $ - $ - Reconciliation of statutory tax rate to the effective income tax rate is as follows: Statutory income tax rate – USA 35.0% Deferred tax asset valuation allowance - USA (35.0)% Statutory income tax rate – Canada 26.5% Deferred tax asset valuation allowance - Canada (26.5)% Deferred tax asset components as of November 30, 2016 and 2015 are as follows: 2016 2015 Non capital losses available to offset future income-taxes $ 19,264,593 $ 17,700,863 Expected Income tax recovery at statutory rates $ (6,472,455 ) $ (6,007,050 ) Valuation Allowance $ 6,472,455 $ 6,007,050 Net deferred tax assets - - As the Company has recognized substantial cumulative losses from operations and has not earned significant revenues, it has provided a 100 per cent valuation allowance on the net deferred tax asset as of November 30, 2016 and 2015. Management believes the Company has no uncertain tax position.

COMMITMENTS

COMMITMENTS	12 Months Ended
	Nov. 30, 2016
COMMITMENTS [Text Block]	11. COMMITMENTS a) Consulting agreements: The non-independent directors of the Company executed consulting agreements with the company on the following terms: Effective October 1, 2014, SDI executed a renewal agreement with a private company in which the Chief Operating Officer Dean Thrasher has an ownership interest in, for a period which expires on December 31, 2017 for services rendered. The total consulting fees are estimated at $648,000 (CAD$864,000) for the three-year period. In the event of termination without cause due to change in control brought out by sale, lease, merger or transfer, the Company is obligated to pay 18 months’ fees at current rate at time of change in control. SDI paid cash and expensed $221,217 (CAD $230,892) during the year ended November 30, 2015. The company may also accept common shares in lieu of cash. As of November 30, 2016, the company has not exercised its right to accept this compensation in shares. Effective February 1, 2015, the Company and director agreed to reduce the monthly remuneration by 10% to $16,200 (CAD $21,600). This reduction continued until the completion of the next round of financing, which was completed in May 2015. On July 16, 2016, Dean Thrasher was appointed interim CEO and President of the Company. Effective August 1, 2016, the Company and director agreed to reduce the monthly consulting fees to $10,550 (CAD $14,000). Effective July 21, 2016, Bryan Ganz was elected as a director of the Company. Prior to his appointment, effective May 1, 2016, the Company executed a one-year consulting agreement with a Corporation in which the said director has an ownership interest. The said Corporation will assist the Company with sales & marketing, expansion of the Company’s product range, review of operations, implementation of cost control measures, development of strategic alliances and financial oversight. For the consultant services and subject to TSX Venture Exchange Inc. (the “Stock Exchange”) approval, the consultant was paid cash for $50,000 and issued a value of $200,000 in Company’s stock in four quarterly installments over the 12 -month period ending May 15, 2017. The first quarterly installment was issued in September 2016. The stock will be priced at the volume weighted average trading price per common share over the 20 - day period preceding the due date. (See also note 18 Subsequent events) Effective November 1, 2013, SDI executed an agreement with a non-related consultant to pay compensation of $3,750 (CAD $5,000) per month. The consultant has agreed to provide corporate market advisory services. The agreement is for a period of a minimum of three months and will continue unless otherwise terminated by either party by giving 30 days’ written notice. Effective May 1, 2015, SDI executed an agreement with another non-related consultant to pay compensation of $3,750 (CAD $5,000) per month. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement unless renewed by mutual consent expires December 31, 2015. The consultant is also entitled to a 5% cash commission for all completed direct sales to end users and a 2% cash commission for all completed indirect sales. In addition, as a sales incentive, the company may grant stock options at market prices, being 25,000 stock options for every 5,000 rounds sold, to a maximum of 200,000 options. Either party may terminate the consulting agreement by giving 60 days’ written notice. Subsequent to the year this agreement was terminated (refer to Note 18) Effective April 2014, SDI executed an agreement with a non-related consultant to set up its social media sites and optimization of search engines for the Company, at a start- up fee for $2,250 (CAD$3,000) (Phase 1) and payment of $2,250 (CAD$3,000) per month and issued 150,000 stock options at $0.32 (CAD$0.38) when Phase 2 of the project was implemented. Either party can terminate the agreement by giving 30 days’ notice. Effective July 1, 2016, SDI renewed an agreement with a non-related consultant to pay compensation of $5,250 per month. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement unless renewed by mutual consent expires December 31, 2016. The consultant is also entitled to a 5% cash commission for all completed direct sales to end users and a 2% cash commission for all completed indirect sales. The Company agreed to grant 25,000 stock options for every 5,000 rounds sold to a maximum of an additional 175,000 options. Either party may terminate the consulting agreement by giving 30 days’ written notice. Subsequent to the year this agreement was terminated (note 18) Effective September 1, 2016, the Company executed an agreement with a non-related consultant to pay compensation of $12,500 per month. The consultant is to assist with sales initiatives, licensing, DOT testing, distributorship set-up and forecast. The agreement expires December 31, 2016, after which the same may continue at Company discretion on a month to month basis. b) The Company has commitments for leasing office premises in Oakville, Ontario, Canada to April 30, 2018 at a monthly rent of $4,800 (CAD $6,399).

EXCLUSIVE SUPPLY AGREEMENT

EXCLUSIVE SUPPLY AGREEMENT	12 Months Ended
	Nov. 30, 2016
EXCLUSIVE SUPPLY AGREEMENT [Text Block]	12. EXCLUSIVE SUPPLY AGREEMENT The Company entered a Development, Supply and Manufacturing Agreement with the BIP Manufacturer on July 25, 2012. This Agreement provides the Company to order and purchase only from the BIP Manufacturer certain 40MM assemblies and components for use by the Company to produce less-lethal and training projectiles as described in the Agreement. The Agreement is for a term of five years with an automatic extension for an additional year if neither party has given written notice of termination prior to the end of the five-year period. The Company and a division of Abrams Airborne Manufacturing Inc. (AAMI), namely Milkor USA (MUSA), agreed to partner for a joint cross-selling / marketing initiative. This arrangement allows both companies to leverage existing and future sales channels by offering a comprehensive, full-package of Milkor USA’s 40mm Multi-Shot Grenade Launchers in conjunction with SDI’s 40mm Less-Lethal ammunition product-line to end-users globally.

SEGMENT DISCLOSURES

SEGMENT DISCLOSURES	12 Months Ended
	Nov. 30, 2016
SEGMENT DISCLOSURES [Text Block]	13. SEGMENT DISCLOSURES The Company is organized on two geographic areas in U.S.A. and Canada respectively. The U.S.A. and Canada operations are our operating segments and reportable segments, and each of those segments are led by our CEO. Performance is assessed and resources are allocated by our CEO, whom we have determined to be our Chief Operating Decision Maker (CODM). Management evaluates the segments based primarily upon revenue and assets. The tables below present segment sales and assets for the fiscal years ended November 30, 2016 and 2015: Year ended November 30, 2016 SDI SDI Canada Total Sales $ 136,230 $ 67,432 $ 203,662 Year ended November 30, 2015 SDI SDI Canada Total Sales $ 144,706 $ 72,575 $ 217,280 2016 2015 Sales $ 203,662 $ 217,280 Elimination of intersegment revenue (49,647 ) (66,275 ) Consolidated sales $ 154,015 151,005 Year ended November 30, 2016 SDI SDI Canada Total Assets $ 316,461 $ 89,398 $ 405,859 Year ended November 30, 2015 SDI SDI Canada Total (Restated) (See Note 17 ) Assets $ 2,036,932 $ 111,348 $ 2,148,280

CONVERTIBLE DEBENTURES AND DEFE

CONVERTIBLE DEBENTURES AND DEFERRED FINANCING COSTS	12 Months Ended
	Nov. 30, 2016
CONVERTIBLE DEBENTURES AND DEFERRED FINANCING COSTS [Text Block]	14. CONVERTIBLE DEBENTURES AND DEFERRED FINANCING COSTS $1,153,540 (CAD $1,549,000) Convertible Debentures On August 6, 2014, the Company issued a Canadian $1,549,000 face value 12% convertible debentures with a term to August 6, 2017 (the “Maturity Date”). At any time while the debentures are outstanding, the holder has the option to convert the outstanding principal of the debentures into common shares of the Company at a fixed conversion price of CAD $0.50 per share. At any time after February 6, 2015, the Company has the right to force the conversion of the debentures into common shares at a price of at least CAD$0.65 per common share for a period of at least 20 consecutive trading days. If the common shares do not trade on any trading day and the bid price of the common Shares is CAD $0.65 or greater, the common shares shall be deemed to have traded at a price of at least CAD $0.65 on that trading day. Additionally, the Company has the right to redeem the debentures, in whole or in part, (a) during the 12 months ending August 6, 2015, at a premium of 15% to the principal amount being redeemed plus any accrued interest, (b) during the 12 months ending August 6, 2016, at a premium of 5% to the principal amount being redeemed plus any accrued interest, (c) during the 12 months ending August 6, 2017, at a premium of 2% to the principal amount being redeemed plus any accrued interest. In connection with the financing, the Company issued warrants to placement agents to purchase 151,900 shares of common stock at an exercise price of CAD $0.50 per share. Additionally, the Company incurred $157,293 (CAD $174,209) in financing fees. The Company has evaluated the terms and conditions of the convertible debentures and placement agent warrants under the guidance of ASC 815. The conversion feature met the definition of conventional convertible for purposes of applying the conventional convertible exemption. The definition of conventional contemplates a fixed number of shares issuable under the arrangement. The instrument was convertible into a fixed number of shares and there were no down round anti-dilution protection features contained in the contracts. The Company was required to consider whether the hybrid contract embodied a beneficial conversion feature (“BCF”). The debentures did not result in a BCF because the conversion price was not in the money on the inception date. There were no terms or features contained in the warrant agreement that would preclude the warrants from achieving equity classification. The following table reflects the allocation of the purchase on the financing date: Convertible Debentures - Face Value $ 1,398,342 Proceeds $ (1,279,773 ) Deferred financing costs (190,876 ) Paid in capital (warrants) 33,583 Prepaid expenses 16,681 Accrued expenses 21,793 Convertible debentures 1,398,592 The warrants were valued at $33,583 and were recorded as a component of deferred financing costs. Interest expense related to the debentures amounted to $232,032 and $231,398 for the years ended November 30, 2016 and 2015 respectively. Of the $232,032 (2015: $231,398) $168,292 (2015: $167,832) related to interest and the remaining $63,740 (2015: $63,566) related to the amortization of deferred financing costs. Deferred financing costs as of November 30, 2016, reflects $35,769 outstanding to be amortized for these convertible debentures. Subsequent to the year there were modifications to the terms of these convertible debentures (refer to note 18) In addition, the Company incurred legal costs for $36,874 during the year ended November 30, 2016, which were costs incurred to raise an additional $1,500,000 of 10% senior secured convertible notes after the year end, and are reflected as deferred financing costs in the balance sheet. (refer to note 18)

INVENTORY

INVENTORY	12 Months Ended
	Nov. 30, 2016
INVENTORY [Text Block]	15. INVENTORY Inventory as of November 30, 2016, consist of finished goods of Blunt Impact Projectiles 40mm for $836 (November 30, 2015: $30,329) and 40mm LMT launchers for $6,487 (November 30, 2015: $13,990) which are held at the BIP manufacturer.

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS	12 Months Ended
	Nov. 30, 2016
FINANCIAL INSTRUMENTS [Text Block]	16. FINANCIAL INSTRUMENTS The Company is exposed to risks that arise from its use of financial instruments. This note describes the Company’s objectives, policies and processes for managing those risks and the methods used to measure them. i) Currency risk The Company held its cash balances within banks in Canada in both United States dollars and Canadian dollars and with banks in United States in United States dollars. The Company’s operations are conducted in USA and its subsidiary operates in Canada. The value of the Canadian dollar against the United States dollar may fluctuate with the changes in economic conditions. During the year ended November 30, 2016, the US dollar strengthened in relation to the Canadian dollar and upon the translation of the Company’s subsidiary’s revenue, expenses, assets and liabilities held in Canadian dollars, the Company recorded translation adjustment loss of $10,619 (Prior year- a loss of $15,033), in other comprehensive loss. The Convertible debentures issued by SDI in Canadian currency reflected a currency gain of $18,749 and $179,537 for the years ended November 30, 2016 and 2015 respectively. The Company's Canadian subsidiary revenue, costs of sales, operating costs and capital expenditures are denominated in Canadian dollar. Consequently, fluctuations in the U.S. dollar exchange rate against the Canadian dollar increases the volatility of sales, cost of sales and operating costs and overall net earnings when translated into U.S. dollars. The Company is not using any forward and option contracts to fix the foreign exchange rates. Using a 10% fluctuations in the US exchange rate, the impact on the loss and stockholders’ deficiency is not material except the effect on the foreign exchange conversion of the convertible debt issued in Canadian dollars. ii) Credit risk and economic dependence Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. The financial instruments that potentially subject the Company to credit risk consist of cash and accounts receivable. The Company maintains cash with high credit quality financial institutions located in Canada. The Company provides credit to its customers in the normal course of its operations. It carries out, on a continuing basis, credit checks on its customers. The Company’s operations rely significantly on one supplier. Notwithstanding the Company has the ability to source alternative suppliers.

PRIOR PERIOD RESTATEMENT

PRIOR PERIOD RESTATEMENT	12 Months Ended
	Nov. 30, 2016
PRIOR PERIOD RESTATEMENT [Text Block]	17. PRIOR PERIOD RESTATEMENT The financial statements as of November 30, 2015 and for the year then ended are restated to record foreign currency translations gains net of tax of $179,537 and $39,167 in fiscal years 2015 and 2014, respectively, following further analysis of convertible debt issued by the Company in Canadian dollars. Accumulated Deficit as of December 1, 2015, has been reduced by $218,704, net of income tax effect of $nil, to correct the cumulative errors for years 2015 and 2014 to include foreign currency translation gain in income statements to conform to generally accepted accounting principles. The analysis was conducted during the preparation of annual financial statements for 2016. The effect of changes in the financial statements is summarized as follows: Year ended Quarter ended Quarter ended Quarter ended Year ended November 30, 2014 February 28, 2015 May 31, 2015 August 31, 2015 November 30, 2015 Prior to Prior to Prior to Prior to Prior to Restatement Restated Restatement Restated Restatement Restated Restatement Restated Restatement Restated $ $ $ $ $ $ $ $ $ $ Consolidated Balance Sheet: Deferred financing costs 170,674 165,230 155,000 137,301 138,978 123,770 122,959 103,510 107,108 88,970 Total Assets 1,557,052 1,551,608 1,011,348 993,649 3,056,766 3,041,558 2,545,867 2,526,418 2,166,418 2,148,280 Convertible Debentures 1,398,592 1,353,981 1,398,592 1,238,890 1,398,592 1,245,551 1,398,592 1,177,395 1,398,592 1,161,750 Total Liabilities 1,559,997 1,515,386 1,514,011 1,354,309 1,524,026 1,370,985 1,459,190 1,237,993 1,571,921 1,335,079 Accumulated deficit (24,042,769 ) (24,003,602 ) (24,531,262 ) (24,389,259 ) (25,000,244 ) (24,862,410 ) (25,467,782 ) (25,266,031 ) (26,593,207 ) (26,374,503 ) Consolidated Statement of operations and Comprehensive loss: Foreign currency translation (gain) loss - (39,167 ) - (102,836 ) - 4,169 - (63,917 ) - (179,537 ) Total Operating Expenses 2,670,074 2,630,907 433,120 330,284 424,010 428,179 414,490 350,573 2,354,105 2,174,568 Loss from Operations (2,654,917 ) (2,615,750 ) (431,436 ) (328,600 ) (410,657 ) (414,826 ) (409,213 ) (345,296 ) (2,319,040 ) (2,139,503 ) Loss before Income Taxes (2,722,412 ) (2,683,245 ) (488,493 ) (385,657 ) (468,982 ) (473,151 ) (467,538 ) (403,621 ) (2,550,438 ) (2,370,901 ) Net Loss (2,722,412 ) (2,683,245 ) (488,493 ) (385,657 ) (468,982 ) (473,151 ) (467,538 ) (403,621 ) (2,550,438 ) (2,370,901 ) Comprehensive Loss (2,754,118 ) (2,714,951 ) (499,718 ) (396,882 ) (464,597 ) (468,766 ) (469,833 ) (405,916 ) (2,565,471 ) (2,385,934 ) Loss per share - basic and diluted (0.06 ) (0.06 ) (0.01 ) (0.01 ) (0.01 ) (0.01 ) (0.01 ) (0.01 ) (0.05 ) (0.05 ) Consolidated Statement of Cash Flows Net Loss (2,722,412 ) (2,683,245 ) (488,493 ) (385,657 ) (957,475 ) (858,808 ) (1,425,013 ) (1,262,429 ) (2,550,438 ) (2,370,901 ) Adjustment for: Foreign currency translation (gain) loss (39,167 ) (102,836 ) (98,667 ) (162,584 ) (179,537 ) Net cash used in operating activities (1,940,050 ) (1,940,050 ) (507,246 ) (507,246 ) (908,650 ) (908,650 ) (1,417,684 ) (1,417,684 ) (1,738,824 ) (1,738,824 )

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Nov. 30, 2016
SUBSEQUENT EVENTS [Text Block]	18. SUBSEQUENT EVENTS a) On December 7, 2016, the Company entered a Securities Purchase Agreement (the “Agreement”) with several accredited investors (the “Purchasers”) and Northeast Industrial Partners, LLC as collateral agent for the Purchasers (the “Collateral Agent”) to sell $1,500,000 of 10% senior secured convertible notes (the “Secured Notes”), convertible into shares of the Company’s common stock, in a private placement pursuant to Regulation D under the Securities Act of 1933 (the “Securities Act”). The sale of the Secured Notes was closed on December 7, 2016. A condition to the sale of the Secured Notes was the exchange of at least 80% in principal amount of the Company’s outstanding 12% Unsecured Debentures, which mature on August 6, 2017 (the “Unsecured Debentures”) for an equal principal amount of Subordinate Secured Debentures. Concurrent with the sale of the Secured Notes, CAD$1,364,000 of the Company’s outstanding Unsecured Debentures, which represented approximately 88% of the outstanding Unsecured Debentures, were exchanged for an equal principal amount of the Subordinate Secured Debentures and an additional CAD$37,000 of Subordinated Secured Debentures were issued in satisfaction of a portion of the accrued interest on the Unsecured Debentures. The outstanding principal amount of the Secured Notes accrues interest at a rate of 10% per annum, provided that, in the event of default on the Secured Notes, the interest rate will be 15.0% during the period of default. The maturity date of the Secured Notes is June 6, 2019, which date is subject to optional extension by each Purchaser if a change of control of the Company is announced prior to such date. Interest on the Secured Notes is payable in arrears on the last day of each May and November while the Secured Notes are outstanding. The Company has the option to redeem the Secured Notes by paying the Purchaser, the Optional Redemption Price as described in the Secured Notes. Each Secured Note is convertible into common stock, at the option of the Purchaser. Upon such optional conversion, the outstanding principal amount of the Secured Note converts into shares of Common Stock at a conversion price of $0.24 per share, subject to adjustment as set forth in the Secured Notes (the “Note Conversion Price”). The Company is not required to convert any portion of a Secured Note if doing so, results in the Purchaser beneficially owning more than 4.99% of the outstanding Common Stock after giving effect to such conversion, provided that on sixty (60) days’ prior written notice from the Purchaser to the Company, that percentage will increase to 19.99% . The CAD$1,364,000 of Subordinate Secured Debentures were issued pursuant to the Indenture in exchange for the Unsecured Debentures in equal principal amount and CAD$37,000 of Subordinate Secured Debentures were issued pursuant to the Indenture in payment of accrued interest. The Subordinate Secured Debentures mature on June 6, 2019 and bear interest at 12% per annum payable, semiannually. The Subordinate Secured Debentures are convertible into common shares of the Company’s Common Stock at the Note Conversion Price so long as any Secured Notes are outstanding, and thereafter, subject to adjustment as set forth in the Indenture. The Company paid to persons who were instrumental in arranging accepted subscription agreements for the Subordinate Secured Debentures, cash compensation equal to 2% of the principal amount of the Subordinate Secured Debentures arranged by such persons. b) In January 2017, the Company made the second share issuance to Northeast Industrial Partners under the consulting agreement announced on June 20, 2016. The Company issued 589,414 common shares at a deemed price of $0.1142 per share to satisfy the payment of USD $50,000 due on November 15, 2016. The shares are subject to a four-month hold period expiring on May 14, 2017. The issuance of shares to Northeast Industrial Partners is the second of four such issuances to occur over the period ending May 15, 2017. Northeast Industrial Partners is controlled by Bryan Ganz, who was appointed to the board of directors of SDI after the consulting agreement was entered. c) Effective January 1, 2017, the Company executed a one-year service agreement with Northeast Industrial Partners, LLC (“NEIP”) a Corporation in which Bryan Ganz, Director has an ownership interest to pay compensation of $7,500 per month. The said Corporation will assist the Company with administrative services which will include accounting, production, inventory management and human resources. The agreement is for a period of one year and can be terminated by either party by giving 60 days’ notice in writing. d) Effective January 1, 2017, the Company executed a commercial lease for leasing warehouse space in Perry, Florida. The lease is for an initial three-year term at a monthly lease payment of $3,250. The said lease can be renewed for an additional three-year term with a 10% increase. e) Effective January 1, 2017, the Company terminated the agreement executed on July 1, 2016 with a non-related consultant to pay compensation of $5,250 per month (refer to Note11) f) Effective January 27, 2017, the Company terminated the agreement executed on May 1, 2015 with a non-related consultant to pay compensation of $3,750 (CAD $5,000) per month (refer to Note11) g) In March 2017, the Company made a third share issuance to Northeast Industrial Partners under the consulting agreement announced on June 20, 2016. The Company issued 503,251 common shares at a deemed price of $0.99 per share to satisfy the payment of $50,000 due on February 15, 2017. The shares are subject to a four-month hold period expiring on July 3, 2017. The issuance of shares to Northeast Industrial Partners is the third of four such issuances to occur over the period ending May 15, 2017. Northeast Industrial Partners is controlled by Bryan Ganz, who was appointed to the board of directors of SDI after the consulting agreement was entered.

Summary of Significant Accoun25

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Nov. 30, 2016
Use of Estimates [Policy Text Block]	a) Use of Estimates The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, and reported amount of revenues and expenses. Significant estimates include accruals, valuation allowance for deferred tax assets, estimates for calculation of stock based compensation, estimating the useful life of its plant and equipment and accounting for conversion features on convertible debt transactions. These estimates are based on management’s best estimates and judgment. Management will adjust such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with certainty, actual results could differ significantly from these estimates.
Income Taxes [Policy Text Block]	b) Income Taxes The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10- 25”). Under ASC 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740- 10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets is not more than likely. The Company did not incur any material impact to its financial condition or results of operations due to the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
Revenue Recognition [Policy Text Block]	c) Revenue Recognition The Company records revenue when it is realized, or realizable and earned. The Company considers revenue to be realized, or realizable and earned, when the following revenue recognition requirements are met: persuasive evidence of an arrangement exists; the products have been delivered to the customer; the sales price is fixed or determinable; and collectability is reasonably assured.
Loss Per Share [Policy Text Block]	d) Loss Per Share Basic loss per share is computed by dividing net loss by the weighted average number of common shares outstanding for the year. Diluted loss per share is computed by dividing net loss by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. There were no common equivalent shares outstanding at November 30, 2016 and 2015 that have been included in dilutive loss per share calculation as the effects would have been anti-dilutive. At November 30, 2016, there were 4,625,000 options and 2,484,650 warrants outstanding, which were convertible into equal number of common shares of the Company. At November 30, 2015, there were 4,750,000 options and 2,767,800 warrants outstanding, which were convertible into equal number of common shares of the Company.
Stock-Based Compensation [Policy Text Block]	e) Stock-Based Compensation All awards granted to employees and non-employees after November 30, 2006 are valued at fair value by using the Black-Scholes option pricing model and recognized on a straight line basis over the service periods of each award. The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees using the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earlier of a performance commitment or completion of performance by the provider of goods or services. If there is a modification of the terms of an award, either by repricing or extending the expiry of the award, the award is re-measured. If the modification results in an increase in the fair value of the new award as compared to the old award immediately prior to the modification, the excess fair value is recognized as compensation expense.
Foreign Currency [Policy Text Block]	f) Foreign Currency The parent Company maintains its books and records in U.S. dollars which is its functional and reporting currency. The Company’s operating subsidiary is a foreign private company and maintains its books and records in Canadian dollars (the functional currency). The subsidiary’s financial statements are converted to US dollars for consolidation purposes. The translation method used is the current rate method. Under the current rate method all assets and liabilities are translated at the current rate, stockholders’ equity accounts are translated at historical rates and revenues and expenses are translated at average rates for the year. The resulting translation adjustment has been included in Accumulated Other Comprehensive Income (Loss).
Comprehensive loss [Policy Text Block]	g) Comprehensive loss Comprehensive loss includes all changes in equity (net assets) during a period from non- owner sources. Items included in comprehensive loss, which are excluded from net loss, include foreign currency translation adjustments relating to its Canadian subsidiary.
Financial Instruments [Policy Text Block]	h) Financial Instruments The carrying amount of accounts and other receivable and accounts payable, approximated their fair value because of the relatively short maturity of these instruments. The Company determines fair value based on its accounting policy fair value measurement i.e. exit price that would be recovered for an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The Company does not use derivative financial instruments such as forwards to hedge foreign currency exposures.
Fair Value Measurement [Policy Text Block]	i) Fair Value Measurement The Company follows ASC 820-10, “Fair Value Measurements and Disclosures” (ASC 820-10), which among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, a three-tier fair value hierarchy has been established, which prioritizes the inputs used in measuring fair value as follows: • • • Assets and liabilities measured at fair value as of November 30, 2016 and 2015 are classified below based on the three fair value hierarchy tiers described above: Carrying Fair Value Value November 30, 2016: Cash $ 192,826 $ 192,826 Accounts receivable $ 32,534 $ 32,534 Accounts payable and accrued liabilities $ 245,911 $ 245,911 Convertible debentures $ 1,153,540 $ 1,153,540 Carrying Fair Value Value (Restated) (Restated) November 30, 2015: (See Note 17) (See Note 17) Cash $ 1,851,021 $ 1,851,021 Accounts receivable $ 39,676 $ 39,676 Accounts payable and accrued liabilities $ 173,329 $ 173,329 Convertible debentures $ 1,161,750 $ 1,161,750 Cash has been measured using Level 1 of the Fair Value Hierarchy The carrying values of cash, accounts receivable, accounts payable and accrued liabilities and convertible debentures approximate their fair values because of the short-term nature of these instruments.
Convertible debt instruments [Policy Text Block]	j) Convertible debt instruments The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 Debt with Conversion and Other Options
Intellectual Property [Policy Text Block]	k) Intellectual Property Five patent applications, four non-provisional and one provisional, have been filed by the Company with the U.S. Patent Office. The Patents have been granted on the four non-provisional patents. Non-Provisional (granted patents): (a) Less-lethal Projectile: This issued patent relates to the Company’s distinctive collapsible ammunition head technology that absorbs kinetic energy of the projectile upon impact. The Corporation’s collapsible head is used in both the BIP and the WEP. (b) Electronic Circuitry for Incapacitating a Living Target: This issued patent relates to the electronic circuitry incapacitation system which forms part of the WEP. The patent describes an electronic circuit which provides an electrical incapacitation current to a living target. (c) Less-lethal Wireless Stun Projectile System for Immobilizing a Target by Neuro-Muscular Disruption: This issued patent describes the process by which the WEP operates with its attachment system to halt a target through a neuro-muscular-disruption system. (d) Autonomous Operation of a Less-lethal Projectile: This patent describes a motion sensing system within the WEP. The sensor will monitor movement of the target and enable the electrical output until the target is subdued. The electrical pulse is programmed for an exact time-frame to specifications of the user. Provisional Patent: (e) Payload carrying arrangement for a non-lethal projectile: This Provisional patent relates to the process of carrying liquid and powder payloads in the head of the BIP munitions that upon impact release from the head and are dispersed upon the target. The Company’s policy has been to write off cost incurred in connection with non-provisional and provisional patent costs as they are incurred as a recoverability of such expenditure is uncertain.
Plant and Equipment [Policy Text Block]	l) Property and Equipment Property and equipment are recorded at cost less accumulated depreciation. Depreciation is provided commencing in the month following acquisition using the following annual rate and method: Computer equipment 30% declining balance method Furniture and fixtures 30% declining balance method Leasehold Improvements straight line over period of lease Moulds 20% Straight line over 5 years
Impairment of Long-lived Assets [Policy Text Block]	m) Impairment of Long-lived Assets Long-lived assets to be held and used are analyzed for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. The Company evaluates at each balance sheet date whether events and circumstances have occurred that indicate possible impairment. If there are indications of impairment, the Company uses future undiscounted cash flows of the related asset or asset group over the remaining life in measuring whether the assets are recoverable. In the event such cash flows are not expected to be sufficient to recover the recorded asset values, the assets are written down to their estimated fair value.
Inventories [Policy Text Block]	n) Inventories Inventories comprise primarily of Blunt Impact Projectiles (Finished goods) and are valued at the lower of cost and net realizable value with cost being determined on the first-in, first-out basis. Costs consist of sub contracted manufacturing costs.
Consolidation [Policy Text Block]	o) Consolidation These consolidated financial statements include the accounts of Security Devices International Inc. and entities it controls. Control exists when SDI has the power, directly or indirectly, to govern the financial and operating policies of an entity/arrangement to obtain benefit from its activities. In assessing control, potential voting rights that currently are exercisable are considered. The financial statement of subsidiaries is included in the consolidated financial statements from the date that control commences until the date that control ceases. These consolidated financial statements include the results of SDI and its wholly-owned subsidiary, Security Devices International Canada Corp.
Recent Accounting Pronouncements [Policy Text Block]	p) Recent Accounting Pronouncements In January 2015, the FASB issued ASU No. 2015-01, "Income Statement - Extraordinary and Unusual Items (Subtopic 225-20) Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items" (ASU 2015-01). The amendments in ASU 2015-01 eliminate the GAAP concept of extraordinary items and no longer requires that transactions that met the criteria for classification as extraordinary items be separately classified and reported in the financial statements. ASU 2015-01 retains the presentation and disclosure guidance for items that are unusual in nature or occur infrequently and expands them to include items that are both unusual in nature and infrequently occurring. ASU 2015-01 will become effective in fiscal 2017. The Company is in the process of evaluating the amendments to determine if they have a material impact on the Company’s financial position, results of operations or cash flow. In February, 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis. ASU No. 2015-02 provides guidance on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities such as limited partnerships, limited liability corporations, and securitization structures (collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). ASU No. 2015-02 is effective for periods beginning after December 15, 2015, with early adoption permitted. The Company is in the process of evaluating the amendments to determine if they have a material impact on the Company’s financial position, results of operations or cash flow. In April 2015, the FASB issued ASU No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. ASU No. 2015-03 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015 with early adoption permitted. The Company is in the process of evaluating the amendments to determine if they have a material impact on the Company’s financial position, results of operations or cash flow. In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes,” as part of its simplification initiative. Under the ASU, organizations that present a classified balance sheet are required to classify all deferred taxes as noncurrent assets or noncurrent liabilities. ASU No. 2015-17 is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company is in the process of evaluating the amendments to determine if they have a material impact on the Company’s financial position, results of operations or cash flow. In January 2016, the FASB issued ASU 2016-01, which makes limited amendments to the guidance in U.S. GAAP on the classification and measurement of financial instruments. The new standard significantly revises an entity’s accounting related to (1) the classification and measurement of investments in equity securities and (2) the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. ASU No. 2016-01 is effective for fiscal years beginning after December 15, 2017, and interim periods within those annual periods. The Company is in the process of evaluating the amendments to determine if they have a material impact on the Company’s financial position, results of operations or cash flow. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) In March 2016, the FASB issued ASU 2016-09, Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing In May 2016, the FASB issued ASU 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments In August 2016, the FASB issued ASU 2016-15, "Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments" (ASU 2016-15. The new guidance clarifies eight cash flow classification issues where current GAAP was either unclear or has no specific guidance. The new standard is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those fiscal years. All entities may elect to early adopt ASU 2016-15 in any interim period. If an entity early adopts it must adopt all eight of the amendments in the same period and if early adopted in an interim period any adjustments should be reflected as of the beginning of the year. The amendments in ASU 2016-15 will be applied using the modified retrospective transition method for each period presented. The Company is evaluating the impact the adoption of this guidance will have on the classification of certain items on its consolidated statements of cash flows. In January 2017, the FASB issued ASU No. 2017-01 Business Combinations (Topic 805) - Clarifying the Definition of a Business. This update clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments provide a screen to determine when a set of assets and activities is not a business. If the screen is not met, the amendments require further consideration of inputs, substantive processes and outputs to determine whether the transaction is an acquisition of a business. The new update is effective for annual periods beginning after December 15, 2017. The amendments in ASU 2017-01 will be implemented on a prospective basis.

SUMMARY OF SIGNIFICANT ACCOUN26

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Carrying Fair Value Value November 30, 2016: Cash $ 192,826 $ 192,826 Accounts receivable $ 32,534 $ 32,534 Accounts payable and accrued liabilities $ 245,911 $ 245,911 Convertible debentures $ 1,153,540 $ 1,153,540	Carrying Fair Value Value (Restated) (Restated) November 30, 2015: (See Note 17) (See Note 17) Cash $ 1,851,021 $ 1,851,021 Accounts receivable $ 39,676 $ 39,676 Accounts payable and accrued liabilities $ 173,329 $ 173,329 Convertible debentures $ 1,161,750 $ 1,161,750
Schedule of Depreciation Rate, Plant and Equipment [Table Text Block]	Computer equipment 30% declining balance method Furniture and fixtures 30% declining balance method Leasehold Improvements straight line over period of lease Moulds 20% Straight line over 5 years

ACCOUNTS PAYABLE AND ACCRUED 27

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)	12 Months Ended
	Nov. 30, 2016
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	2016 2015 Accounts payable and accrued liabilities are comprised of the following: Trade payables $ 85,603 $ 69,962 Accrued liabilities-accrued interest $ 54,259 $ 53,339 Accrued liabilities-other liabilities $ 106,049 $ 50,028 $ 245,911 $ 173,329

STOCK BASED COMPENSATION (Table

STOCK BASED COMPENSATION (Tables)	12 Months Ended
	Nov. 30, 2016
Schedule of Share-based Compensation and Assumptions as of June 9, 2016 [Table Text Block]	Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% 101.25% to Volatility 150.29% Warrant modification expense $ 49,912
Schedule of Share-based Compensation and Assumptions as of August 18, 2016 [Table Text Block]	Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 163.68% Market price of Company’s common stock on date of grant of options $ 0.11 Stock-based compensation cost $ 2,574
Schedule of Share-based Compensation and Assumptions as of October 20, 2016 [Table Text Block]	Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 149.08% Market price of Company’s common stock on date of grant of options $0.08 Stock-based compensation cost $25,450
Schedule of Share-based Compensation and Assumptions as of September 24, 2015 [Table Text Block]	Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% 17.29% to Volatility 134.39% Warrant modification expense $ 216,684
Schedule of Share-based Compensation and Assumptions as of October 20, 2015 [Table Text Block]	Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 134.39% Market price of Company’s common stock on date of grant of options $ 0.29 Stock-based compensation cost $ 422,459

STOCK PURCHASE OPTIONS AND WA29

STOCK PURCHASE OPTIONS AND WARRANTS (Tables)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Number of options 2016 2015 Outstanding, beginning of year 4,750,000 3,360,000 Granted 375,000 1,675,000 Expired (100,000 ) (200,000 ) Exercised - (35,000 ) Forfeited - - Cancelled (400,000 ) (50,000 ) Outstanding, end of year 4,625,000 4,750,000 Exercisable, end of year 4,625,000 4,750,000
Schedule of Share-based Compensation, Stock Options [Table Text Block]	Year 2016 Number of Option price options Expiry date per share 2016 March 18, 2017 $ 0.31 350,000 August 5, 2017 $ 0.32 150,000 May 8, 2019 $ 0.32 600,000 September 10, 2019 $ 0.36 1,625,000 October 19, 2020 $ 0.29 1,525,000 August 17, 2021 $ 0.11 25,000 October 19, 2021 $ 0.08 350,000 TOTAL 4,625,000 Weighted average exercise price: Options outstanding at end of year $ 0.30 Options granted during the year 0.08 Options exercised during the year - Options expired during the year 0.45 Options cancelled during the year 0.33	Year 2015 Number of Option price options Expiry date per share 2015 October 25, 2016 $ 0.45 100,000 March 18, 2017 $ 0.31 350,000 August 5, 2017 $ 0.32 150,000 May 8, 2019 $ 0.32 600,000 September 10, 2019 $ 0.36 1,875,000 October 19, 2020 $ 0.29 1,675,000 TOTAL 4,750,000 Weighted average exercise price: Options outstanding at end of year $ 0.33 Options granted during the year 0.29 Options exercised during the year 0.20 Options expired during the year 0.42 Options cancelled during the year 0.31
Share-based Compensation Arrangement by Share-based Payment Award, Remaining Contractual Term, Outstanding and Exercisable [Table Text Block]	2016 2015 (Years) (Years) Total outstanding options 2.8 3.8 Total exercisable options 2.8 3.8
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]	Number of Warrants Exercise Expiry Granted Prices Date $ Outstanding at November 30, 2014 and average exercise price 4,794,545 0.24 Granted in year 2015 - - Exercised (27,500 ) 0.20 Exercised (68,750 ) 0.13 Exercised (9,350 ) 0.25 Forfeited - - Expired (622,500 ) 0.20 Expired (75,000 ) 0.42 Expired (1,223,645 ) 0.47 Cancelled - - Outstanding at November 30, 2015 and average exercise price* 2,767,800 0.17 Granted in year 2016 - - Exercised - - Expired (131,250 ) 0.13 Expired (151,900 ) 0.45 Cancelled - - Outstanding at November 30, 2016 and average exercise price* 2,484,650 0.16 Exercisable at November 30, 2016 2,484,650 0.16 Exercisable at November 30, 2015 2,767,800 0.17
Schedule of Stockholders' Equity Note, Warrants or Rights, Weighted Average Remaining Contractual Term, Outstanding and Exercisable [Table Text Block]	2016 2015 (Years) (Years) Total outstanding warrants 3.25 2.87 Total exercisable warrants 3.25 2.87

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Nov. 30, 2016
Schedule of Property, Plant and Equipment [Table Text Block]	November November 30, 2016 Accumulated 30, 2015 Accumulated Cost Depreciation Cost Depreciation $ $ $ $ Computer equipment 37,573 35,410 37,573 34,483 Furniture and fixtures 18,027 16,648 18,027 16,057 Leasehold Improvements 23,721 19,338 23,721 16,244 Moulds 209,515 166,944 209,515 125,041 288,836 238,340 288,836 191,825 Net carrying amount $ 50,496 $ 97,011 Depreciation expense $ 46,515 $ 47,165

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Nov. 30, 2016
Summary of Tax Credit Carryforwards [Table Text Block]	USA Canada Total 2025 $ 188,494 188,494 2026 609,991 609,991 2027 1,731,495 1,731,495 2028 3,174,989 3,174,989 2029 2,792,560 2,792,560 2030 2,044,857 2,044,857 2031 854,218 854,218 2032 1,073,610 1,073,610 2033 1,410,557 1,410,557 2034 882,513 1,089,850 1,972,363 2035 722,853 1,124,876 1,847,729 2036 600,185 963,545 1,563,730 $ 16,086,322 3,178,271 19,264,593
Schedule of Reconcilation of Income Tax Expense [Table Text Block]	November November 30, 2016 30, 2015 (Restated) (See Note 17 ) Loss before income taxes $ (1,924,110 ) $ (2,331,734 ) Income tax recovery at statutory rate (592,327 ) (728,692 ) Permanent differences 49,587 245,949 Tax benefit not recognized 542,740 482,743 Income taxes – current and deferred $ - $ -
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Statutory income tax rate – USA 35.0% Deferred tax asset valuation allowance - USA (35.0)% Statutory income tax rate – Canada 26.5% Deferred tax asset valuation allowance - Canada (26.5)%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	2016 2015 Non capital losses available to offset future income-taxes $ 19,264,593 $ 17,700,863 Expected Income tax recovery at statutory rates $ (6,472,455 ) $ (6,007,050 ) Valuation Allowance $ 6,472,455 $ 6,007,050 Net deferred tax assets - -

SEGMENT DISCLOSURES (Tables)

SEGMENT DISCLOSURES (Tables)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]		SDI SDI Canada Total Sales $ 144,706 $ 72,575 $ 217,280
Schedule of Segment Reporting Information, by Segment [Table Text Block]	2016 2015 Sales $ 203,662 $ 217,280 Elimination of intersegment revenue (49,647 ) (66,275 ) Consolidated sales $ 154,015 151,005
Sales [Member]
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	SDI SDI Canada Total Sales $ 136,230 $ 67,432 $ 203,662
Assets [Member]
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	SDI SDI Canada Total Assets $ 316,461 $ 89,398 $ 405,859	SDI SDI Canada Total (Restated) (See Note 17 ) Assets $ 2,036,932 $ 111,348 $ 2,148,280

CONVERTIBLE DEBENTURES AND DE33

CONVERTIBLE DEBENTURES AND DEFERRED FINANCING COSTS (Tables)	12 Months Ended
	Nov. 30, 2016
Schedule of Convertible Debt [Table Text Block]	Convertible Debentures - Face Value $ 1,398,342 Proceeds $ (1,279,773 ) Deferred financing costs (190,876 ) Paid in capital (warrants) 33,583 Prepaid expenses 16,681 Accrued expenses 21,793 Convertible debentures 1,398,592

PRIOR PERIOD RESTATEMENT (Table

PRIOR PERIOD RESTATEMENT (Tables)	12 Months Ended
	Nov. 30, 2016
Condensed Financial Statements [Table Text Block]	Year ended Quarter ended Quarter ended Quarter ended Year ended November 30, 2014 February 28, 2015 May 31, 2015 August 31, 2015 November 30, 2015 Prior to Prior to Prior to Prior to Prior to Restatement Restated Restatement Restated Restatement Restated Restatement Restated Restatement Restated $ $ $ $ $ $ $ $ $ $ Consolidated Balance Sheet: Deferred financing costs 170,674 165,230 155,000 137,301 138,978 123,770 122,959 103,510 107,108 88,970 Total Assets 1,557,052 1,551,608 1,011,348 993,649 3,056,766 3,041,558 2,545,867 2,526,418 2,166,418 2,148,280 Convertible Debentures 1,398,592 1,353,981 1,398,592 1,238,890 1,398,592 1,245,551 1,398,592 1,177,395 1,398,592 1,161,750 Total Liabilities 1,559,997 1,515,386 1,514,011 1,354,309 1,524,026 1,370,985 1,459,190 1,237,993 1,571,921 1,335,079 Accumulated deficit (24,042,769 ) (24,003,602 ) (24,531,262 ) (24,389,259 ) (25,000,244 ) (24,862,410 ) (25,467,782 ) (25,266,031 ) (26,593,207 ) (26,374,503 ) Consolidated Statement of operations and Comprehensive loss: Foreign currency translation (gain) loss - (39,167 ) - (102,836 ) - 4,169 - (63,917 ) - (179,537 ) Total Operating Expenses 2,670,074 2,630,907 433,120 330,284 424,010 428,179 414,490 350,573 2,354,105 2,174,568 Loss from Operations (2,654,917 ) (2,615,750 ) (431,436 ) (328,600 ) (410,657 ) (414,826 ) (409,213 ) (345,296 ) (2,319,040 ) (2,139,503 ) Loss before Income Taxes (2,722,412 ) (2,683,245 ) (488,493 ) (385,657 ) (468,982 ) (473,151 ) (467,538 ) (403,621 ) (2,550,438 ) (2,370,901 ) Net Loss (2,722,412 ) (2,683,245 ) (488,493 ) (385,657 ) (468,982 ) (473,151 ) (467,538 ) (403,621 ) (2,550,438 ) (2,370,901 ) Comprehensive Loss (2,754,118 ) (2,714,951 ) (499,718 ) (396,882 ) (464,597 ) (468,766 ) (469,833 ) (405,916 ) (2,565,471 ) (2,385,934 ) Loss per share - basic and diluted (0.06 ) (0.06 ) (0.01 ) (0.01 ) (0.01 ) (0.01 ) (0.01 ) (0.01 ) (0.05 ) (0.05 ) Consolidated Statement of Cash Flows Net Loss (2,722,412 ) (2,683,245 ) (488,493 ) (385,657 ) (957,475 ) (858,808 ) (1,425,013 ) (1,262,429 ) (2,550,438 ) (2,370,901 ) Adjustment for: Foreign currency translation (gain) loss (39,167 ) (102,836 ) (98,667 ) (162,584 ) (179,537 ) Net cash used in operating activities (1,940,050 ) (1,940,050 ) (507,246 ) (507,246 ) (908,650 ) (908,650 ) (1,417,684 ) (1,417,684 ) (1,738,824 ) (1,738,824 )

NATURE OF OPERATIONS AND GOIN35

NATURE OF OPERATIONS AND GOING CONCERN (Narrative) (Details) - 12 months ended Nov. 30, 2016	USD ($)shares	CADshares
Nature Of Operations And Going Concern 1	$ 28,298,613
Nature Of Operations And Going Concern 2	878,328
Nature Of Operations And Going Concern 3	910,000
Nature Of Operations And Going Concern 4	$ 649,750
Nature Of Operations And Going Concern 5 | shares	2,165,834	2,165,834
Nature Of Operations And Going Concern 6 | CAD		CAD 3,993,980
Nature Of Operations And Going Concern 7	$ 3,794,280
Nature Of Operations And Going Concern 8	9,984,950	9,984,950
Nature Of Operations And Going Concern 9 | CAD		CAD 0.40
Nature Of Operations And Going Concern 10	$ 0.38
Nature Of Operations And Going Concern 11	$ 1,398,592
Nature Of Operations And Going Concern 12 | CAD		CAD 1,549,000
Nature Of Operations And Going Concern 13	12.00%	12.00%
Nature Of Operations And Going Concern 14	$ 1,241,299
Nature Of Operations And Going Concern 15	$ 2,500,000
Nature Of Operations And Going Concern 16 | shares	7,575,757	7,575,757
Nature Of Operations And Going Concern 17 | shares	105,600	105,600
Nature Of Operations And Going Concern 18	$ 16,775
Nature Of Operations And Going Concern 19 | shares	35,000	35,000
Nature Of Operations And Going Concern 20	$ 6,995
Nature Of Operations And Going Concern 21	$ 1,500,000

SUMMARY OF SIGNIFICANT ACCOUN36

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)	12 Months Ended
	Nov. 30, 2016shares
Summary Of Significant Accounting Policies 1	4,625,000
Summary Of Significant Accounting Policies 2	2,484,650
Summary Of Significant Accounting Policies 3	4,750,000
Summary Of Significant Accounting Policies 4	2,767,800

CAPITAL STOCK (Narrative) (Deta

CAPITAL STOCK (Narrative) (Details) - 12 months ended Nov. 30, 2016	USD ($)shares	CAD / shares
Capital Stock 1	100,000,000
Capital Stock 2	$ 0.001
Capital Stock 3 | shares	5,000,000
Capital Stock 4	$ 0.001
Capital Stock 5	$ 0.001
Capital Stock 6	50,000,000
Capital Stock 7 | shares	100,000,000
Capital Stock 8 | shares	5,000,000
Capital Stock 9	$ 0.001
Capital Stock 10 | shares	55,104,493
Capital Stock 11 | shares	54,615,642
Capital Stock 12	$ 50,000
Capital Stock 13	$ 200,000
Capital Stock 14	12
Capital Stock 15	488,851
Capital Stock 16	$ 50,000
Capital Stock 17	16,775
Capital Stock 18	$ 6,995
Capital Stock 19 | shares	105,600
Capital Stock 20 | shares	35,000
Capital Stock 21	7,575,757
Capital Stock 22	$ 0.33
Capital Stock 23 | CAD / shares		CAD 0.40
Capital Stock 24	$ 2,500,000

STOCK BASED COMPENSATION (Narra

STOCK BASED COMPENSATION (Narrative) (Details) - 12 months ended Nov. 30, 2016	USD ($)shares	CADCAD / sharesshares
Stock Based Compensation 1	12	12
Stock Based Compensation 2	2.00%	2.00%
Stock Based Compensation 3	12	12
Stock Based Compensation 4	2.00%	2.00%
Stock Based Compensation 5	12	12
Stock Based Compensation 6	10.00%	10.00%
Stock Based Compensation 7	12	12
Stock Based Compensation 8 | CAD		CAD 0.10
Stock Based Compensation 9 | shares	400,000	400,000
Stock Based Compensation 10 | $	$ 0.20
Stock Based Compensation 11 | shares	400,000	400,000
Stock Based Compensation 12 | $	$ 49,912
Stock Based Compensation 13 | shares	25,000	25,000
Stock Based Compensation 14 | $	$ 0.11
Stock Based Compensation 15 | CAD / shares		CAD 0.14
Stock Based Compensation 16 | shares	350,000	350,000
Stock Based Compensation 17 | $	$ 0.08
Stock Based Compensation 18 | CAD / shares		CAD 0.11
Stock Based Compensation 19 | $	$ 0
Stock Based Compensation 20 | shares	572,000	572,000
Stock Based Compensation 21 | $	$ 0.20
Stock Based Compensation 22 | shares	1,470,000	1,470,000
Stock Based Compensation 23	35,000	35,000
Stock Based Compensation 24 | $	$ 0.13
Stock Based Compensation 25 | shares	2,077,000	2,077,000
Stock Based Compensation 26 | $	$ 216,684
Stock Based Compensation 27 | shares	1,350,000	1,350,000
Stock Based Compensation 28 | shares	325,000	325,000
Stock Based Compensation 29 | shares	1,675,000	1,675,000
Stock Based Compensation 30 | $	$ 0.29
Stock Based Compensation 31 | CAD / shares		CAD 0.38
Stock Based Compensation 32 | $	$ 0

STOCK PURCHASE OPTIONS AND WA39

STOCK PURCHASE OPTIONS AND WARRANTS (Narrative) (Details)	12 Months Ended
	Nov. 30, 2016yrshares
Stock Purchase Options And Warrants 1	572,000
Stock Purchase Options And Warrants 2	1,505,000
Stock Purchase Options And Warrants 3	400,000
Stock Purchase Options And Warrants 4 | yr	4

RELATED PARTY TRANSACTIONS (Nar

RELATED PARTY TRANSACTIONS (Narrative) (Details)	12 Months Ended
	Nov. 30, 2016USD ($)shares	Nov. 30, 2016CADCAD / sharesshares
Related Party Transactions 1	$ 219,000
Related Party Transactions 2	57,600
Related Party Transactions 3	5,900
Related Party Transactions 4	$ 42,200
Related Party Transactions 5 | shares	400,000	400,000
Related Party Transactions 6	$ 0.20
Related Party Transactions 7 | shares	400,000	400,000
Related Party Transactions 8	$ 49,912
Related Party Transactions 9 | shares	350,000	350,000
Related Party Transactions 10	$ 0.08
Related Party Transactions 11 | CAD / shares		CAD 0.11
Related Party Transactions 12	25,450
Related Party Transactions 13	25,000
Related Party Transactions 14	$ 25,000
Related Party Transactions 15 | shares	488,851	488,851
Related Party Transactions 16	$ 0.1023
Related Party Transactions 17 | CAD		CAD 0.1322
Related Party Transactions 18	50,000
Related Party Transactions 19	32,000
Related Party Transactions 20	186,800
Related Party Transactions 21	50,780
Related Party Transactions 22	212,505
Related Party Transactions 23	$ 5,721
Related Party Transactions 24 | shares	572,000	572,000
Related Party Transactions 25	$ 0.20
Related Party Transactions 26 | shares	1,470,000	1,470,000
Related Party Transactions 27	$ 0.13
Related Party Transactions 28 | shares	2,042,000	2,042,000
Related Party Transactions 29	$ 213,603
Related Party Transactions 30 | shares	1,350,000	1,350,000
Related Party Transactions 31	$ 0.29
Related Party Transactions 32 | CAD / shares		CAD 0.38
Related Party Transactions 33	$ 340,489
Related Party Transactions 34 | shares	1,325,000	1,325,000
Related Party Transactions 35	$ 35,717
Related Party Transactions 36	221,217
Related Party Transactions 37	$ 89,538

INCOME TAXES (Narrative) (Detai

INCOME TAXES (Narrative) (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Income Taxes 1	$ 1
Income Taxes 32	35.00%
Income Taxes 33	26.50%
Income Taxes 58	100.00%

COMMITMENTS (Narrative) (Detail

COMMITMENTS (Narrative) (Details) - 12 months ended Nov. 30, 2016	USD ($)modCAD / mo$ / moshares	CADmodCAD / mo$ / moshares
Commitments 1	$ 648,000
Commitments 2 | CAD		CAD 864,000
Commitments 3 | mo	18	18
Commitments 4	$ 221,217
Commitments 5 | CAD		CAD 230,892
Commitments 6	10.00%	10.00%
Commitments 7	$ 16,200
Commitments 8 | CAD		CAD 21,600
Commitments 9	10,550
Commitments 10 | CAD		CAD 14,000
Commitments 11	50,000
Commitments 12	$ 200,000
Commitments 13	12	12
Commitments 14	20	20
Commitments 15	$ 3,750
Commitments 16 | CAD / mo	5,000	5,000
Commitments 17 | d	30	30
Commitments 18	$ 3,750
Commitments 19 | CAD / mo	5,000	5,000
Commitments 20	5.00%	5.00%
Commitments 21	2.00%	2.00%
Commitments 22 | shares	25,000	25,000
Commitments 23	5,000	5,000
Commitments 24 | shares	200,000	200,000
Commitments 25 | d	60	60
Commitments 26	$ 2,250
Commitments 27 | CAD		CAD 3,000
Commitments 28	$ 2,250
Commitments 29 | CAD / mo	3,000	3,000
Commitments 30 | shares	150,000	150,000
Commitments 31	$ 0.32
Commitments 32 | CAD		CAD 0.38
Commitments 33 | d	30	30
Commitments 34 | $ / mo	5,250	5,250
Commitments 35	5.00%	5.00%
Commitments 36	2.00%	2.00%
Commitments 37 | shares	25,000	25,000
Commitments 38	5,000	5,000
Commitments 39 | shares	175,000	175,000
Commitments 40 | d	30	30
Commitments 41 | $ / mo	12,500	12,500
Commitments 42	$ 4,800
Commitments 43 | CAD		CAD 6,399

CONVERTIBLE DEBENTURES AND DE43

CONVERTIBLE DEBENTURES AND DEFERRED FINANCING COSTS (Narrative) (Details) - 12 months ended Nov. 30, 2016	USD ($)moshares	CADmoCAD / sharesshares
Convertible Debentures And Deferred Financing Costs 1	$ 1,153,540
Convertible Debentures And Deferred Financing Costs 2 | CAD		CAD 1,549,000
Convertible Debentures And Deferred Financing Costs 3	$ 1,549,000
Convertible Debentures And Deferred Financing Costs 4	12.00%	12.00%
Convertible Debentures And Deferred Financing Costs 5 | CAD / shares		CAD 0.50
Convertible Debentures And Deferred Financing Costs 6 | CAD		CAD 0.65
Convertible Debentures And Deferred Financing Costs 7	20	20
Convertible Debentures And Deferred Financing Costs 8 | CAD		CAD 0.65
Convertible Debentures And Deferred Financing Costs 9 | CAD		CAD 0.65
Convertible Debentures And Deferred Financing Costs 10 | mo	12	12
Convertible Debentures And Deferred Financing Costs 11	15.00%	15.00%
Convertible Debentures And Deferred Financing Costs 12 | mo	12	12
Convertible Debentures And Deferred Financing Costs 13	5.00%	5.00%
Convertible Debentures And Deferred Financing Costs 14 | mo	12	12
Convertible Debentures And Deferred Financing Costs 15	2.00%	2.00%
Convertible Debentures And Deferred Financing Costs 16 | shares	151,900	151,900
Convertible Debentures And Deferred Financing Costs 17 | CAD / shares		CAD 0.50
Convertible Debentures And Deferred Financing Costs 18	$ 157,293
Convertible Debentures And Deferred Financing Costs 19 | CAD		CAD 174,209
Convertible Debentures And Deferred Financing Costs 27	33,583
Convertible Debentures And Deferred Financing Costs 28	232,032
Convertible Debentures And Deferred Financing Costs 29	231,398
Convertible Debentures And Deferred Financing Costs 30	232,032
Convertible Debentures And Deferred Financing Costs 31	231,398
Convertible Debentures And Deferred Financing Costs 32	168,292
Convertible Debentures And Deferred Financing Costs 33	167,832
Convertible Debentures And Deferred Financing Costs 34	63,740
Convertible Debentures And Deferred Financing Costs 35	63,566
Convertible Debentures And Deferred Financing Costs 36	35,769
Convertible Debentures And Deferred Financing Costs 37	36,874
Convertible Debentures And Deferred Financing Costs 38	$ 1,500,000
Convertible Debentures And Deferred Financing Costs 39	10.00%	10.00%

INVENTORY (Narrative) (Details)

INVENTORY (Narrative) (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Inventory 1	$ 836
Inventory 2	30,329
Inventory 3	6,487
Inventory 4	$ 13,990

FINANCIAL INSTRUMENTS (Narrativ

FINANCIAL INSTRUMENTS (Narrative) (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Financial Instruments 1	$ 10,619
Financial Instruments 2	15,033
Financial Instruments 3	18,749
Financial Instruments 4	$ 179,537
Financial Instruments 5	10.00%

PRIOR PERIOD RESTATEMENT (Narra

PRIOR PERIOD RESTATEMENT (Narrative) (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Prior Period Restatement 1	$ 179,537
Prior Period Restatement 2	39,167
Prior Period Restatement 3	218,704
Prior Period Restatement 4	$ 0

SUBSEQUENT EVENTS (Narrative) (

SUBSEQUENT EVENTS (Narrative) (Details) - 12 months ended Nov. 30, 2016	USD ($)d$ / sharesCAD / mo$ / moshares	CADdCAD / mo$ / moshares
Subsequent Events 1	$ 1,500,000
Subsequent Events 2	10.00%	10.00%
Subsequent Events 3	1,933	1,933
Subsequent Events 4	80.00%	80.00%
Subsequent Events 5	12.00%	12.00%
Subsequent Events 6 | CAD		CAD 1,364,000
Subsequent Events 7	88.00%	88.00%
Subsequent Events 8 | CAD		CAD 37,000
Subsequent Events 9	10.00%	10.00%
Subsequent Events 10	15.00%	15.00%
Subsequent Events 11 | $ / shares	$ 0.24
Subsequent Events 12	4.99%	4.99%
Subsequent Events 13	19.99%	19.99%
Subsequent Events 14 | CAD		CAD 1,364,000
Subsequent Events 15 | CAD		CAD 37,000
Subsequent Events 16	12.00%	12.00%
Subsequent Events 17	2.00%	2.00%
Subsequent Events 18 | shares	589,414	589,414
Subsequent Events 19 | $ / shares	$ 0.1142
Subsequent Events 20	$ 50,000
Subsequent Events 21 | $ / mo	7,500	7,500
Subsequent Events 22 | d	60	60
Subsequent Events 23	$ 3,250
Subsequent Events 24	10.00%	10.00%
Subsequent Events 25 | $ / mo	5,250	5,250
Subsequent Events 26	$ 3,750
Subsequent Events 27 | CAD / mo	5,000	5,000
Subsequent Events 28 | shares	503,251	503,251
Subsequent Events 29 | $ / shares	$ 0.99
Subsequent Events 30	$ 50,000

Schedule of Fair Value, Assets

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 1	$ 192,826
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 2	192,826
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 3	32,534
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 4	32,534
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 5	245,911
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 6	245,911
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 7	1,153,540
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 8	$ 1,153,540
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 1		$ 1,851,021
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 2		1,851,021
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 3		39,676
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 4		39,676
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 5		173,329
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 6		173,329
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 7		1,161,750
Summary Of Significant Accounting Policies Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis 8		$ 1,161,750

Schedule of Depreciation Rate,

Schedule of Depreciation Rate, Plant and Equipment (Details)	12 Months Ended
	Nov. 30, 2016yr
Summary Of Significant Accounting Policies Schedule Of Depreciation Rate, Plant And Equipment 1	30.00%
Summary Of Significant Accounting Policies Schedule Of Depreciation Rate, Plant And Equipment 2	30.00%
Summary Of Significant Accounting Policies Schedule Of Depreciation Rate, Plant And Equipment 3	20.00%
Summary Of Significant Accounting Policies Schedule Of Depreciation Rate, Plant And Equipment 4	5

Schedule of Accounts Payable an

Schedule of Accounts Payable and Accrued Liabilities (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 1	$ 85,603
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 2	69,962
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 3	54,259
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 4	53,339
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 5	106,049
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 6	50,028
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 7	245,911
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 8	$ 173,329

Schedule of Share-based Compens

Schedule of Share-based Compensation and Assumptions as of June 9, 2016 (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of June 9, 2016 1	2.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of June 9, 2016 2	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of June 9, 2016 3	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of June 9, 2016 4	101.25%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of June 9, 2016 5	150.29%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of June 9, 2016 6	$ 49,912

Schedule of Share-based Compe52

Schedule of Share-based Compensation and Assumptions as of August 18, 2016 (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of August 18, 2016 1	2.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of August 18, 2016 2	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of August 18, 2016 3	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of August 18, 2016 4	163.68%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of August 18, 2016 5	0.11
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of August 18, 2016 6	$ 2,574

Schedule of Share-based Compe53

Schedule of Share-based Compensation and Assumptions as of October 20, 2016 (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 20, 2016 1	2.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 20, 2016 2	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 20, 2016 3	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 20, 2016 4	149.08%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 20, 2016 5	$ 0.08
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 20, 2016 6	$ 25,450

Schedule of Share-based Compe54

Schedule of Share-based Compensation and Assumptions as of September 24, 2015 (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of September 24, 2015 1	2.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of September 24, 2015 2	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of September 24, 2015 3	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of September 24, 2015 4	17.29%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of September 24, 2015 5	134.39%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of September 24, 2015 6	$ 216,684

Schedule of Share-based Compe55

Schedule of Share-based Compensation and Assumptions as of October 20, 2015 (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 20, 2015 1	2.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 20, 2015 2	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 20, 2015 3	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 20, 2015 4	134.39%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 20, 2015 5	0.29
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of October 20, 2015 6	$ 422,459

Schedule of Share-based Compe56

Schedule of Share-based Compensation, Stock Options, Activity (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 1	$ 4,750,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 2	3,360,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 3	375,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 4	1,675,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 5	(100,000)
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 6	(200,000)
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 7	0
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 8	(35,000)
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 9	0
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 10	0
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 11	(400,000)
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 12	(50,000)
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 13	4,625,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 14	4,750,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 15	4,625,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 16	$ 4,750,000

Schedule of Share-based Compe57

Schedule of Share-based Compensation, Stock Options (Details)	12 Months Ended
	Nov. 30, 2016USD ($)	Nov. 30, 2015USD ($)
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 1	0.31
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 2	$ 350,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 3	0.32
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 4	$ 150,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 5	0.32
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 6	$ 600,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 7	0.36
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 8	$ 1,625,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 9	0.29
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 10	$ 1,525,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 11	0.11
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 12	$ 25,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 13	0.08
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 14	$ 350,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 15	$ 4,625,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 16	0.30
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 17	0.08
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 18	$ 0
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 19	0.45
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 20	0.33
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 1		0.45
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 2		$ 100,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 3		0.31
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 4		$ 350,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 5		0.32
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 6		$ 150,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 7		0.32
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 8		$ 600,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 9		0.36
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 10		$ 1,875,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 11		0.29
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 12		$ 1,675,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 13		$ 4,750,000
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 14		0.33
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 15		0.29
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 16		0.20
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 17		0.42
Stock Purchase Options And Warrants Schedule Of Share-based Compensation, Stock Options 18		0.31

Share-based Compensation Arrang

Share-based Compensation Arrangement by Share-based Payment Award, Remaining Contractual Term, Outstanding and Exercisable (Details)	12 Months Ended
	Nov. 30, 2016
Stock Purchase Options And Warrants Share-based Compensation Arrangement By Share-based Payment Award, Remaining Contractual Term, Outstanding And Exercisable 1	2.8
Stock Purchase Options And Warrants Share-based Compensation Arrangement By Share-based Payment Award, Remaining Contractual Term, Outstanding And Exercisable 2	3.8
Stock Purchase Options And Warrants Share-based Compensation Arrangement By Share-based Payment Award, Remaining Contractual Term, Outstanding And Exercisable 3	2.8
Stock Purchase Options And Warrants Share-based Compensation Arrangement By Share-based Payment Award, Remaining Contractual Term, Outstanding And Exercisable 4	3.8

Schedule of Stockholders' Equit

Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 1	$ 4,794,545
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 2	0.24
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 3	$ 0
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 4	0
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 5	$ (27,500)
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 6	0.20
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 7	$ (68,750)
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 8	0.13
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 9	$ (9,350)
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 10	0.25
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 11	$ 0
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 12	0
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 13	$ (622,500)
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 14	0.20
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 15	$ (75,000)
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 16	0.42
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 17	$ (1,223,645)
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 18	0.47
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 19	$ 0
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 20	0
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 21	$ 2,767,800
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 22	0.17
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 23	$ 0
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 24	0
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 25	0
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 26	0
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 27	$ (131,250)
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 28	0.13
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 29	$ (151,900)
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 30	0.45
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 31	$ 0
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 32	0
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 33	$ 2,484,650
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 34	0.16
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 35	$ 2,484,650
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 36	0.16
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 37	$ 2,767,800
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 38	0.17

Schedule of Stockholders' Equ60

Schedule of Stockholders' Equity Note, Warrants or Rights, Weighted Average Remaining Contractual Term, Outstanding and Exercisable (Details)	12 Months Ended
	Nov. 30, 2016
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Weighted Average Remaining Contractual Term, Outstanding And Exercisable 1	3.25
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Weighted Average Remaining Contractual Term, Outstanding And Exercisable 2	2.87
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Weighted Average Remaining Contractual Term, Outstanding And Exercisable 3	3.25
Stock Purchase Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Weighted Average Remaining Contractual Term, Outstanding And Exercisable 4	2.87

Schedule of Property, Plant and

Schedule of Property, Plant and Equipment (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Property And Equipment Schedule Of Property, Plant And Equipment 1	$ 37,573
Property And Equipment Schedule Of Property, Plant And Equipment 2	35,410
Property And Equipment Schedule Of Property, Plant And Equipment 3	37,573
Property And Equipment Schedule Of Property, Plant And Equipment 4	34,483
Property And Equipment Schedule Of Property, Plant And Equipment 5	18,027
Property And Equipment Schedule Of Property, Plant And Equipment 6	16,648
Property And Equipment Schedule Of Property, Plant And Equipment 7	18,027
Property And Equipment Schedule Of Property, Plant And Equipment 8	16,057
Property And Equipment Schedule Of Property, Plant And Equipment 9	23,721
Property And Equipment Schedule Of Property, Plant And Equipment 10	19,338
Property And Equipment Schedule Of Property, Plant And Equipment 11	23,721
Property And Equipment Schedule Of Property, Plant And Equipment 12	16,244
Property And Equipment Schedule Of Property, Plant And Equipment 13	209,515
Property And Equipment Schedule Of Property, Plant And Equipment 14	166,944
Property And Equipment Schedule Of Property, Plant And Equipment 15	209,515
Property And Equipment Schedule Of Property, Plant And Equipment 16	125,041
Property And Equipment Schedule Of Property, Plant And Equipment 17	288,836
Property And Equipment Schedule Of Property, Plant And Equipment 18	238,340
Property And Equipment Schedule Of Property, Plant And Equipment 19	288,836
Property And Equipment Schedule Of Property, Plant And Equipment 20	191,825
Property And Equipment Schedule Of Property, Plant And Equipment 21	50,496
Property And Equipment Schedule Of Property, Plant And Equipment 22	97,011
Property And Equipment Schedule Of Property, Plant And Equipment 23	46,515
Property And Equipment Schedule Of Property, Plant And Equipment 24	$ 47,165

Summary of Tax Credit Carryforw

Summary of Tax Credit Carryforwards (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Income Taxes Summary Of Tax Credit Carryforwards 1	$ 188,494
Income Taxes Summary Of Tax Credit Carryforwards 2	188,494
Income Taxes Summary Of Tax Credit Carryforwards 3	609,991
Income Taxes Summary Of Tax Credit Carryforwards 4	609,991
Income Taxes Summary Of Tax Credit Carryforwards 5	1,731,495
Income Taxes Summary Of Tax Credit Carryforwards 6	1,731,495
Income Taxes Summary Of Tax Credit Carryforwards 7	3,174,989
Income Taxes Summary Of Tax Credit Carryforwards 8	3,174,989
Income Taxes Summary Of Tax Credit Carryforwards 9	2,792,560
Income Taxes Summary Of Tax Credit Carryforwards 10	2,792,560
Income Taxes Summary Of Tax Credit Carryforwards 11	2,044,857
Income Taxes Summary Of Tax Credit Carryforwards 12	2,044,857
Income Taxes Summary Of Tax Credit Carryforwards 13	854,218
Income Taxes Summary Of Tax Credit Carryforwards 14	854,218
Income Taxes Summary Of Tax Credit Carryforwards 15	1,073,610
Income Taxes Summary Of Tax Credit Carryforwards 16	1,073,610
Income Taxes Summary Of Tax Credit Carryforwards 17	1,410,557
Income Taxes Summary Of Tax Credit Carryforwards 18	1,410,557
Income Taxes Summary Of Tax Credit Carryforwards 19	882,513
Income Taxes Summary Of Tax Credit Carryforwards 20	1,089,850
Income Taxes Summary Of Tax Credit Carryforwards 21	1,972,363
Income Taxes Summary Of Tax Credit Carryforwards 22	722,853
Income Taxes Summary Of Tax Credit Carryforwards 23	1,124,876
Income Taxes Summary Of Tax Credit Carryforwards 24	1,847,729
Income Taxes Summary Of Tax Credit Carryforwards 25	600,185
Income Taxes Summary Of Tax Credit Carryforwards 26	963,545
Income Taxes Summary Of Tax Credit Carryforwards 27	1,563,730
Income Taxes Summary Of Tax Credit Carryforwards 28	16,086,322
Income Taxes Summary Of Tax Credit Carryforwards 29	3,178,271
Income Taxes Summary Of Tax Credit Carryforwards 30	$ 19,264,593

Schedule of Reconcilation of In

Schedule of Reconcilation of Income Tax Expense (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 1	$ 30
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 2	30
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 3	(1,924,110)
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 4	(2,331,734)
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 5	(592,327)
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 6	(728,692)
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 7	49,587
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 8	245,949
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 9	542,740
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 10	482,743
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 11	0
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 12	$ 0

Schedule of Effective Income Ta

Schedule of Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Nov. 30, 2016
Income Taxes Schedule Of Effective Income Tax Rate Reconciliation 1	35.00%
Income Taxes Schedule Of Effective Income Tax Rate Reconciliation 2	(35.00%)
Income Taxes Schedule Of Effective Income Tax Rate Reconciliation 3	26.50%
Income Taxes Schedule Of Effective Income Tax Rate Reconciliation 4	(26.50%)

Schedule of Deferred Tax Assets

Schedule of Deferred Tax Assets and Liabilities (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1	$ 19,264,593
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2	17,700,863
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3	(6,472,455)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4	(6,007,050)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5	6,472,455
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6	6,007,050
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7	0
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8	$ 0

Schedule of Revenue from Extern

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details) - USD ($)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
Segment Disclosures Set Schedule Title Here 1		$ 144,706
Segment Disclosures Set Schedule Title Here 2		72,575
Segment Disclosures Set Schedule Title Here 3		217,280
Sales [Member]
Segment Disclosures Schedule Of Revenue From External Customers And Long-lived Assets, By Geographical Areas 1	$ 136,230
Segment Disclosures Schedule Of Revenue From External Customers And Long-lived Assets, By Geographical Areas 2	67,432
Segment Disclosures Schedule Of Revenue From External Customers And Long-lived Assets, By Geographical Areas 3	203,662
Assets [Member]
Segment Disclosures Schedule Of Revenue From External Customers And Long-lived Assets, By Geographical Areas 1	316,461
Segment Disclosures Schedule Of Revenue From External Customers And Long-lived Assets, By Geographical Areas 2	89,398
Segment Disclosures Schedule Of Revenue From External Customers And Long-lived Assets, By Geographical Areas 3	$ 405,859
Segment Disclosures Schedule Of Revenue From External Customers And Long-lived Assets, By Geographical Areas 1		2,036,932
Segment Disclosures Schedule Of Revenue From External Customers And Long-lived Assets, By Geographical Areas 2		111,348
Segment Disclosures Schedule Of Revenue From External Customers And Long-lived Assets, By Geographical Areas 3		$ 2,148,280

Schedule of Segment Reporting I

Schedule of Segment Reporting Information, by Segment (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Segment Disclosures Schedule Of Segment Reporting Information, By Segment 1	$ 203,662
Segment Disclosures Schedule Of Segment Reporting Information, By Segment 2	217,280
Segment Disclosures Schedule Of Segment Reporting Information, By Segment 3	(49,647)
Segment Disclosures Schedule Of Segment Reporting Information, By Segment 4	(66,275)
Segment Disclosures Schedule Of Segment Reporting Information, By Segment 5	154,015
Segment Disclosures Schedule Of Segment Reporting Information, By Segment 6	$ 151,005

Schedule of Convertible Debt (D

Schedule of Convertible Debt (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 1	$ 1,398,342
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 2	(1,279,773)
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 3	(190,876)
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 4	33,583
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 5	16,681
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 6	21,793
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 7	$ 1,398,592

Condensed Financial Statements

Condensed Financial Statements (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Prior Period Restatement Condensed Financial Statements 1	$ 170,674
Prior Period Restatement Condensed Financial Statements 2	165,230
Prior Period Restatement Condensed Financial Statements 3	155,000
Prior Period Restatement Condensed Financial Statements 4	137,301
Prior Period Restatement Condensed Financial Statements 5	138,978
Prior Period Restatement Condensed Financial Statements 6	123,770
Prior Period Restatement Condensed Financial Statements 7	122,959
Prior Period Restatement Condensed Financial Statements 8	103,510
Prior Period Restatement Condensed Financial Statements 9	107,108
Prior Period Restatement Condensed Financial Statements 10	88,970
Prior Period Restatement Condensed Financial Statements 11	1,557,052
Prior Period Restatement Condensed Financial Statements 12	1,551,608
Prior Period Restatement Condensed Financial Statements 13	1,011,348
Prior Period Restatement Condensed Financial Statements 14	993,649
Prior Period Restatement Condensed Financial Statements 15	3,056,766
Prior Period Restatement Condensed Financial Statements 16	3,041,558
Prior Period Restatement Condensed Financial Statements 17	2,545,867
Prior Period Restatement Condensed Financial Statements 18	2,526,418
Prior Period Restatement Condensed Financial Statements 19	2,166,418
Prior Period Restatement Condensed Financial Statements 20	2,148,280
Prior Period Restatement Condensed Financial Statements 21	1,398,592
Prior Period Restatement Condensed Financial Statements 22	1,353,981
Prior Period Restatement Condensed Financial Statements 23	1,398,592
Prior Period Restatement Condensed Financial Statements 24	1,238,890
Prior Period Restatement Condensed Financial Statements 25	1,398,592
Prior Period Restatement Condensed Financial Statements 26	1,245,551
Prior Period Restatement Condensed Financial Statements 27	1,398,592
Prior Period Restatement Condensed Financial Statements 28	1,177,395
Prior Period Restatement Condensed Financial Statements 29	1,398,592
Prior Period Restatement Condensed Financial Statements 30	1,161,750
Prior Period Restatement Condensed Financial Statements 31	1,559,997
Prior Period Restatement Condensed Financial Statements 32	1,515,386
Prior Period Restatement Condensed Financial Statements 33	1,514,011
Prior Period Restatement Condensed Financial Statements 34	1,354,309
Prior Period Restatement Condensed Financial Statements 35	1,524,026
Prior Period Restatement Condensed Financial Statements 36	1,370,985
Prior Period Restatement Condensed Financial Statements 37	1,459,190
Prior Period Restatement Condensed Financial Statements 38	1,237,993
Prior Period Restatement Condensed Financial Statements 39	1,571,921
Prior Period Restatement Condensed Financial Statements 40	1,335,079
Prior Period Restatement Condensed Financial Statements 41	(24,042,769)
Prior Period Restatement Condensed Financial Statements 42	(24,003,602)
Prior Period Restatement Condensed Financial Statements 43	(24,531,262)
Prior Period Restatement Condensed Financial Statements 44	(24,389,259)
Prior Period Restatement Condensed Financial Statements 45	(25,000,244)
Prior Period Restatement Condensed Financial Statements 46	(24,862,410)
Prior Period Restatement Condensed Financial Statements 47	(25,467,782)
Prior Period Restatement Condensed Financial Statements 48	(25,266,031)
Prior Period Restatement Condensed Financial Statements 49	(26,593,207)
Prior Period Restatement Condensed Financial Statements 50	(26,374,503)
Prior Period Restatement Condensed Financial Statements 51	0
Prior Period Restatement Condensed Financial Statements 52	(39,167)
Prior Period Restatement Condensed Financial Statements 53	0
Prior Period Restatement Condensed Financial Statements 54	(102,836)
Prior Period Restatement Condensed Financial Statements 55	0
Prior Period Restatement Condensed Financial Statements 56	4,169
Prior Period Restatement Condensed Financial Statements 57	0
Prior Period Restatement Condensed Financial Statements 58	(63,917)
Prior Period Restatement Condensed Financial Statements 59	0
Prior Period Restatement Condensed Financial Statements 60	(179,537)
Prior Period Restatement Condensed Financial Statements 61	2,670,074
Prior Period Restatement Condensed Financial Statements 62	2,630,907
Prior Period Restatement Condensed Financial Statements 63	433,120
Prior Period Restatement Condensed Financial Statements 64	330,284
Prior Period Restatement Condensed Financial Statements 65	424,010
Prior Period Restatement Condensed Financial Statements 66	428,179
Prior Period Restatement Condensed Financial Statements 67	414,490
Prior Period Restatement Condensed Financial Statements 68	350,573
Prior Period Restatement Condensed Financial Statements 69	2,354,105
Prior Period Restatement Condensed Financial Statements 70	2,174,568
Prior Period Restatement Condensed Financial Statements 71	(2,654,917)
Prior Period Restatement Condensed Financial Statements 72	(2,615,750)
Prior Period Restatement Condensed Financial Statements 73	(431,436)
Prior Period Restatement Condensed Financial Statements 74	(328,600)
Prior Period Restatement Condensed Financial Statements 75	(410,657)
Prior Period Restatement Condensed Financial Statements 76	(414,826)
Prior Period Restatement Condensed Financial Statements 77	(409,213)
Prior Period Restatement Condensed Financial Statements 78	(345,296)
Prior Period Restatement Condensed Financial Statements 79	(2,319,040)
Prior Period Restatement Condensed Financial Statements 80	(2,139,503)
Prior Period Restatement Condensed Financial Statements 81	(2,722,412)
Prior Period Restatement Condensed Financial Statements 82	(2,683,245)
Prior Period Restatement Condensed Financial Statements 83	(488,493)
Prior Period Restatement Condensed Financial Statements 84	(385,657)
Prior Period Restatement Condensed Financial Statements 85	(468,982)
Prior Period Restatement Condensed Financial Statements 86	(473,151)
Prior Period Restatement Condensed Financial Statements 87	(467,538)
Prior Period Restatement Condensed Financial Statements 88	(403,621)
Prior Period Restatement Condensed Financial Statements 89	(2,550,438)
Prior Period Restatement Condensed Financial Statements 90	(2,370,901)
Prior Period Restatement Condensed Financial Statements 91	(2,722,412)
Prior Period Restatement Condensed Financial Statements 92	(2,683,245)
Prior Period Restatement Condensed Financial Statements 93	(488,493)
Prior Period Restatement Condensed Financial Statements 94	(385,657)
Prior Period Restatement Condensed Financial Statements 95	(468,982)
Prior Period Restatement Condensed Financial Statements 96	(473,151)
Prior Period Restatement Condensed Financial Statements 97	(467,538)
Prior Period Restatement Condensed Financial Statements 98	(403,621)
Prior Period Restatement Condensed Financial Statements 99	(2,550,438)
Prior Period Restatement Condensed Financial Statements 100	(2,370,901)
Prior Period Restatement Condensed Financial Statements 101	(2,754,118)
Prior Period Restatement Condensed Financial Statements 102	(2,714,951)
Prior Period Restatement Condensed Financial Statements 103	(499,718)
Prior Period Restatement Condensed Financial Statements 104	(396,882)
Prior Period Restatement Condensed Financial Statements 105	(464,597)
Prior Period Restatement Condensed Financial Statements 106	(468,766)
Prior Period Restatement Condensed Financial Statements 107	(469,833)
Prior Period Restatement Condensed Financial Statements 108	(405,916)
Prior Period Restatement Condensed Financial Statements 109	(2,565,471)
Prior Period Restatement Condensed Financial Statements 110	$ (2,385,934)
Prior Period Restatement Condensed Financial Statements 111	(0.06)
Prior Period Restatement Condensed Financial Statements 112	(0.06)
Prior Period Restatement Condensed Financial Statements 113	(0.01)
Prior Period Restatement Condensed Financial Statements 114	(0.01)
Prior Period Restatement Condensed Financial Statements 115	(0.01)
Prior Period Restatement Condensed Financial Statements 116	(0.01)
Prior Period Restatement Condensed Financial Statements 117	(0.01)
Prior Period Restatement Condensed Financial Statements 118	(0.01)
Prior Period Restatement Condensed Financial Statements 119	(0.05)
Prior Period Restatement Condensed Financial Statements 120	(0.05)
Prior Period Restatement Condensed Financial Statements 121	$ (2,722,412)
Prior Period Restatement Condensed Financial Statements 122	(2,683,245)
Prior Period Restatement Condensed Financial Statements 123	(488,493)
Prior Period Restatement Condensed Financial Statements 124	(385,657)
Prior Period Restatement Condensed Financial Statements 125	(957,475)
Prior Period Restatement Condensed Financial Statements 126	(858,808)
Prior Period Restatement Condensed Financial Statements 127	(1,425,013)
Prior Period Restatement Condensed Financial Statements 128	(1,262,429)
Prior Period Restatement Condensed Financial Statements 129	(2,550,438)
Prior Period Restatement Condensed Financial Statements 130	(2,370,901)
Prior Period Restatement Condensed Financial Statements 131	(39,167)
Prior Period Restatement Condensed Financial Statements 132	(102,836)
Prior Period Restatement Condensed Financial Statements 133	(98,667)
Prior Period Restatement Condensed Financial Statements 134	(162,584)
Prior Period Restatement Condensed Financial Statements 135	(179,537)
Prior Period Restatement Condensed Financial Statements 136	(1,940,050)
Prior Period Restatement Condensed Financial Statements 137	(1,940,050)
Prior Period Restatement Condensed Financial Statements 138	(507,246)
Prior Period Restatement Condensed Financial Statements 139	(507,246)
Prior Period Restatement Condensed Financial Statements 140	(908,650)
Prior Period Restatement Condensed Financial Statements 141	(908,650)
Prior Period Restatement Condensed Financial Statements 142	(1,417,684)
Prior Period Restatement Condensed Financial Statements 143	(1,417,684)
Prior Period Restatement Condensed Financial Statements 144	(1,738,824)
Prior Period Restatement Condensed Financial Statements 145	$ (1,738,824)